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This dissertation consists of three research topics.
In the first part, we present deep fiducial inference and approximate fiducial compu-
tation (AFC) algorithm. Since the mid-2000s, there has been a resurrection of interest in
modern modifications of fiducial inference. To date, the main computational tool to extract
a generalized fiducial distribution is Markov chain Monte Carlo (MCMC). We propose an
alternative way of computing a generalized fiducial distribution that could be used in com-
plex situations. In particular, to overcome the difficulty when the unnormalized fiducial
density (needed for MCMC) is intractable, we design a fiducial autoencoder (FAE). The
fitted FAE is used to generate generalized fiducial samples of the unknown parameters. To
increase accuracy, we then apply an approximate fiducial computation (AFC) algorithm,
by rejecting samples that do not replicate the observed data well enough when plugged
into a decoder. Our numerical experiments show the effectiveness of our FAE-based inverse
solution and the excellent coverage performance of the AFC corrected FAE solution.
In the second part, we present SMNN, a supervised mutual nearest neighbor method, for
batch effect correction in single-cell RNA-sequencing (scRNA-seq) data. Batch effect correc-
tion has been recognized to be indispensable when integrating single-cell RNA sequencing
(scRNA-seq) data from multiple batches. State-of-the-art methods ignore single-cell cluster
label information, but such information can improve the effectiveness of batch effect correc-
tion, particularly under realistic scenarios where biological differences are not orthogonal
to batch effects. To address this issue, we propose SMNN for batch effect correction of
scRNA-seq data via supervised mutual nearest neighbor detection. Our extensive evalua-
tions in simulated and real datasets show that SMNN provides improved merging within
the corresponding cell types across batches, leading to reduced differentiation across batches
iii
over alternative methods including MNN, Seurat v3 and LIGER. Furthermore, SMNN re-
tains more cell-type-specific features, partially manifested by differentially expressed genes
identified between cell types after SMNN correction being biologically more relevant, with
precision improving by up to 841.0%.
In the third part, we present an ensemble imputation framework for DNA methylation
across different platforms. DNA methylation at CpG dinucleotides is a biological process
by which methyl groups are added to the DNA molecule. It is one of the most exten-
sively studied epigenetic marks. With technological advancements, geneticists can profile
DNA methylation with multiple reliable approaches. However, different profiling platforms
can differ substantially in the density and measurements for the CpGs they assess, con-
sequently hindering joint analysis across platforms. For this project, we focus on the two
most commonly used commercial methylation platforms from the Illumina company, specif-
ically aiming to impute from the HumanMethylation450 (HM450) BeadChip to 850K CpG
sites on the HumanMethylationEPIC (HM850) BeadChip. We present CUE, CpG imputa-
tion Ensemble, which ensemble multiple classical statistical and modern machine learning
methods. Our results highlight CUE as a valuable tool for imputing from HM450 to HM850.
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With the advancement of technology and the volume of big data, data science and statistics
play even more important roles in the 21st century’s genetics and epigenetics than before. In
particular, machine learning methods are of increasing importance in both foundations of statistical
inference and modern genetics applications. This dissertation contains two parts. In the first
part of this dissertation (Chapter 2), we focus on the foundation of the inference problem. We
introduce a new inference framework, deep fiducial inference, accompanied by a computational
algorithm, approximate fiducial computation. This new framework provides an alternate approach
to generalized fiducial inference, compared to the traditional MCMC-like approach, and is designed
for big data circumstances.
Since the mid-2000s, there has been a resurrection of interest in modern modifications of fiducial
inference. To date, the main computational tool to extract a generalized fiducial distribution is
MCMC and MCMC derived methods. We aim to propose an alternative way of computing a
generalized fiducial distribution via inverse solutions. The main idea of the inverse solution is
to use the inverse function or the approximate inverse function as a sampler to directly generate
fiducial samples, and then get the kernel density estimation of fiducial distribution without knowing
the analytical density form, which might be difficult or impossible to calculate. With the fiducial
distribution built on the inverse solution, typical inference can be carried on. The main challenges
for this project are how to approximate the inverse function and how to generate fiducial samples
lives on the data manifold. Deep fiducial inference framework employs deep neural networks to
approximate the inverse function and approximate fiducial computation is an algorithm that uses
a reject-sampling scheme to generate valid fiducial samples. The competitive performance of AFC
corrected FAE solutions both in terms of efficiency and accuracy suggests that this is a promising
area for future research.
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In the second part of this dissertation (Chapters 3 and 4), we introduce one application in
genetics in Chapter 3 and one application in epigenetics in Chapter 4. Although the methods we
built and improved for those two applications are rooted in two particular examples, they can also
be generalized to other situations. However, for the brevity and consistency in each chapter, we
focus on the motivated application itself in this dissertation.
An ever-increasing amount of single-cell RNA-sequencing (scRNA-seq) data has been generated
as scRNA-seq technologies mature and sequencing costs continue dropping. However, large-scale
scRNA-seq data, for example, those profiling tens of thousands to millions of cells (such as the Hu-
man Cell Atlas Project (Rozenblatt-Rosen et al., 2017), almost inevitably involve multiple batches
across time points, laboratories, or experimental protocols. The presence of batch effect renders
joint analysis across batches challenging (Chen and Zhou, 2017; Stegle et al., 2015). Batch effect, or
systematic differences in gene expression profiles across batches, not only can obscure the true un-
derlying biology, but also may lead to spurious findings. Thus, batch effect correction, which aims
to mitigate the discrepancies across batches, is crucial and deemed indispensable for the analysis
of scRNA-seq data across batches (Stuart and Satija, 2019a). Because of its importance, several
batch effects correction methods have been recently proposed and implemented. However, when
applied to scRNA-seq data, the corrected results derived from these methods widely adopted for
bulk RNA-seq data might be even inferior to raw data without no correction, in some extreme cases
(Haghverdi et al., 2018).
To address the heterogeneity and high dimensionality of complex data, we present SMNN, a su-
pervised mutual nearest neighbor method, for batch effect correction in single-cell RNA-sequencing
(scRNA-seq) data in Chapter 3. An ever-increasing deluge of scRNA-seq data has been generated,
often involving different time points, laboratories, or sequencing protocols. Batch effect correction
has been recognized to be indispensable when integrating scRNA-seq data from multiple batches.
SMNN either takes cluster/cell-type label information as input or infers cell types using scRNA-seq
clustering in the absence of such information. It then detects mutual nearest neighbors within
matched cell types and corrects batch effect accordingly. Compared to other state-of-arts batch
effects correction methods, SMNN provides improved merging within the corresponding cell types
across batches and retains more cell-type-specific features after correction.
2
We next consider an application in epigenetics. DNA methylation of cytosine residues at
CpG dinucleotides is one of the most extensively studied epigenetic marks. Rich recent literature
provides evidence regarding its important role not only in normal development but also in risk
and progression to many diseases (Bird, 2002; Gonzalo, 2010; Joubert et al., 2016; Klutstein et al.,
2016; Iurlaro et al., 2017; Horvath and Raj, 2018; Turecki and Meaney, 2016; Bakusic et al., 2017).
With the emergence of powerful technologies such as DNA methylation microarray (Bibikova et al.,
2011b) and bisulfite sequencing, geneticists can profile DNA methylation at increasingly higher
resolutions. Taking methylation microarrays for an example, we have witnessed new platforms
replacing old ones every few years (Moran et al., 2016; Bibikova et al., 2009; Dedeurwaerder et al.,
2014). However, different platforms (for example, the widely used Illumina HumanMethylation27,
HumanMethylation450, MethylationEPIC BeadChips) target different CpG sites and have different
marker densities, consequently hindering joint analysis across platforms.
In Chapter 4, we aim to impute an HM450 dataset up to an HM850 dataset, for increased
coverage of this epigenomic landscape. Specifically, we present CUE, CpG imputation Ensemble,
which ensemble multiple classical statistical and modern machine learning methods, to impute
from the Illumina HumanMethylation450 (HM450) BeadChip to 850K CpG sites on the Illumina
HumanMethylationEPIC (HM850) BeadChip. We analyzed data from two population cohorts
measured both by HM450 and HM850: the Extremely Low Gestational Age Newborns (ELGAN)
study (n=127, placenta) and the Posttraumatic Stress Disorder (PTSD) study (n=144, whole
blood). Our results highlight CUE as a valuable tool for imputing from HM450 to HM850.
3
CHAPTER 2
Deep Fiducial Inference and Approximate Fiducial Computation
2.1 Introduction
Generalized fiducial inference (GFI) (Hannig et al., 2016), a modern re-incarnation of R. A.
Fisher’s fiducial inference (Fisher, 1930), provides inferentially meaningful probability statements
about subsets of parameter space without the need for subjective prior information. GFI specifies
a generalized fiducial distribution (GFD) by defining a data-dependent measure on the parameter
space through an inverse of a data-generating algorithm (see Sections 2.3). The data-generating
algorithm plays the role of a model and is sometimes called data-generating equation or data-
generating function. With GFD as a distribution estimator for the fixed parameter(s), we can
further define approximate confidence (fiducial) sets which are often shown in simulation to have
very desired properties (Hannig et al., 2016).
Given the data-generating algorithm and the corresponding density of the GFD, one can form
point estimates and asymptotic confidence sets similarly to a Bayesian posterior density. Standard
MCMC-type sampling techniques have already been successfully implemented in many situations;
see (Hannig et al., 2016) and the references therein. However, sometimes the generalized fiducial
density can be hard to compute. Especially when the likelihood function of the data is intractable,
MCMC may be difficult or impossible to implement. For this reason we propose using a deep neural
network to approximate the nonlinear inverse to the data-generating algorithm, and to generate an
approximation to the fiducial distribution without knowing the exact form the density.
Autoencoder (AE) (Hinton and Zemel, 1994; Schmidhuber, 2015) is a type of neural network
architecture to learn data code, an efficient representation of the data, and to reduce data di-
mensions. Different variants of autoencoder (Vincent et al., 2010) have gained a lot of successful
results in applications of the neural network, such as variational autoencoder (Doersch, 2016) and
variational Bayes (Kingma and Welling, 2013). The denoising autoencoder (Vincent et al., 2008)
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is designed to remove the noise effects without losing the essential signal in the data. Inspired
by the autoencoder’s architecture, we design an FAE, which continues to use a neural network as
the encoder to approximate the inverse of data generating function but employs the exact data-
generating function as the decoder. Furthermore, we design and implement approximate fiducial
computation algorithms, in addition to FAE, to generate generalized fiducial samples.
The rest of this chapter is organized as follows. In Section 2.2, we first introduce the generalized
fiducial inference and its standard MCMC based solution. In Section 2.3.1, we design a fiducial
autoencoder (FAE) to approximate the inverse function when it is not directly available, and we also
propose the approximate fiducial computation (AFC) algorithm to further increase the accuracy of
FAE. We demonstrate the performance of FAE and AFC in four numerical examples in Section 2.4.
Section 2.5 concludes the chapter with some discussions.
2.2 Background on generalized fiducial inference
Before introducing our computational tool, FAE, we first briefly present the current state of
ideas in GFI. The GFI framework is based on linking the observed data x, the unknown parameter
µ, and some random component z via a data generating algorithm, also called data generating
function. We shall discuss this in detail.
Data generating algorithm: The data generating algorithm is
x = f(z, µ). (2.1)
where x is the data, µ is the parameter, and z is a random component with random distribution
F0, e.g., i.i.d. standard Gaussian distribution, that is completely known and independent of the
parameter µ. It is assumed that the data could have been generated by fixing some parameter
value µ, generating a value z from distribution F0, and plugging them into the equation (2.1). The
data x is assumed observed, while the values of µ and z are unobserved. Notice that this procedure
uniquely determines the sampling distribution of x, and µ is fixed.
Generalized fiducial distribution: If both x and z were known, then inverting equation
(2.1), i.e., solving for µ, would give us the unknown parameter. Heuristically speaking, since z is
unknown, we estimate it using its distribution F0 and define GFD by propagating the distribution
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F0 through the inverse of the data generating algorithm. More precisely, GFD is defined rigorously
as follows (Hannig et al., 2016):
For an ε > 0, consider the following inverse problem
g(x, z) = argmin
µ?
‖x− f(z, µ?)‖. (2.2)
In this chapter we will use ‖ · ‖ as either `2 or Frobenius norm and call the inverse of the data
generating algorithm g(x, z) the inverse function. Next define the random variable µ?ε = g(x,Z
?
ε ),
where Z?ε has distribution F0 truncated to the set
Cε = {Z?ε : ‖x− f(Z?ε , µ?ε )‖ = ‖x− f(Z?ε , g(x,Z?ε ))‖ ≤ ε}. (2.3)
Then assuming that the random variable µ?ε converges in distribution as ε → 0, GFD is de-
fined as the limiting distribution µ? = limε→0 µ
?
ε . In practice, a small threshold ε is selected for
computation. Notice that the fiducial distribution of µ? depends on the observed data x.
With this GFD as the distribution estimator for µ, one can form point estimators and construct
approximate confidence sets just like using a Bayesian posterior distribution. Notice that GFI does
not need any prior information, and in fact, it provides a systematic approach to deriving objective
Bayes-like posterior distributions (Hannig et al., 2016). The following theorem is a basis for most
current numerical implementations of GFD:




L (x|µ′) J (x,µ′) dµ′




, where ∇µ is a
gradient matrix with respect to µ and D(A) = (detA′A)
1
2 .
Notice that the form of the GFD density in the theorem has a similar form to a Bayesian poste-
rior density, where the Jacobian function J(x, µ) plays the role of a data-dependent prior. Similarly
to Bayesian inference, one potential challenge using this formula to calculate the fiducial density
is that the denominator might be intractable. Traditionally this has been addressed using MCMC
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algorithms. There are many well-known challenges associated with MCMC such as computational
speeds and intractable high dimensional integrals. In particular, MCMC is difficult to implement
when a closed form of the likelihood is unknown or difficult to derive.
In this chapter, we propose a sampling-based computational solution using (2.2) directly. There
are two main challenges in implementing this approach. First, the solution to the optimization
problem in (2.2) might not have an analytical form or might be difficult to calculate. Therefore we
propose to approximate the solution g(x,Z?ε ) using a deep neural network (see details in section
2.3.1). Second, one needs to generate Z?ε from Cε for a small ε, which could be very challenging
when C0 is a lower dimensional-manifold. We propose an AFC algorithm (see details in section
2.3.2) to effectively generate fiducial samples.
Confidence curve: before proceeding further, we also introduce the confidence curve (CC),
a useful graphical tool for plotting epistemic distributions (Birnbaum, 1961). Given Rx(µ) the
distribution function of GFD corresponding to a one-dimensional marginal of density in Theorem 1,
CC is defined as 2|Rx(µ) − 0.5|. CC shows two-sided confidence intervals at all significance levels
stacked upon each other (e.g., see Figure 2.1 ). The median of GFD is the point where CC touches
x-axis and can be used as a point estimator.
Figure 2.1: Confidence curve.
See Figure 2.1: a vertical line shows the true parameter value, while a horizontal line with
height α (0 < α < 1) across the CC provides an α level, equal tailed, two-sided confidence interval.
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2.3 Methodology
2.3.1 Deep fiducial inference
Before we introduce our FAE, we first discuss some terminology used within deep learning
(Goodfellow et al., 2016). Artificial neural network is a function described using a directed graph.
The vertices are simple functions, typically a linear function with output modified by a non-linear
function called an activation function. Examples of activation functions include the identity, called
linear activation function, max(x, 0), called ReLU (Nair and Hinton, 2010), sigmoid function, hy-
perbolic tangent function, etc. Activation functions are called squashing if their range is a compact
interval. The edges of the graph describe the relationships between inputs and outputs of the simple
functions. A feedforward neural network, the most basic type of neural network, is an artificial
neural network wherein connections between the nodes do not form a cycle. Training neural net-
work describes the process of fitting the coefficients of the linear functions in the nodes of the graph
to training data. This is typically done using a stochastic optimization algorithm, e.g., stochastic
gradient descent (SGD) (Bottou, 2010) or Adam (Kingma and Ba, 2014).
In this section, we design a fiducial FAE, a deep neural network based approximation for the
inverse function (2.2), for circumstances where the inverse function might not have an analytical
form or might be difficult to calculate. There are standard theoretical guarantees for a good
approximation (Hornik et al., 1989) (Theorem 2) and our numerical experiments in Section 2.4 also
validate this approach.
Theorem 2 (Universal Approximation Theorem). A feedforward network with a linear output layer
and at least one hidden layer with any squashing activation functions can approximate any Borel
measurable function, provided that the network is given enough hidden units.
The most basic version of autoencoder (AE) (Hinton and Zemel, 1994; Schmidhuber, 2015)
often contains two parts, encoder and decoder. The encoder maps from the observation space X
to latent coder space Z while the decoder does the inverse (see left panel of Figure 2.2).
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Figure 2.2: Autoencoder and fiducial inference. The left panel shows a schematic of a generic autoencoder
while the right panel compares autoencoder with usual generalized fiducial inference.
We compare the encode-decode process of the standard AE to the usual fiducial inference in the
right panel of Figure 2.2. The process by which the data generating function maps the parameter
and the latent variables to the observations is similar to the mechanism by which the decoder maps
the code to the data in the usual AE. Similarly, the encoder in AE plays a role akin to the inverse
of the data generating algorithm in fiducial inference. Inspired by this analogy, we create the FAE
framework which will use as an encoder a neural network that will approximate the inverse of
the data generating algorithm µ̂ = g(x, z) to be estimated, and as a decoder the data generating
algorithm x̂ = f(z, µ̂) that is known to us.
Figure 2.3: Standard fiducial autoencoder architecture.
More precisely, the standard FAE has two input nodes, the observation data x and the latent
variable z, one final output node, the prediction x̂, and one intermediate output node, the prediction
µ̂. The FAE’s encoder usually consists of a deep fully connected neural network, which maps the x
and z to µ̂. The architecture of the encoder is flexible and should be selected based on the problem
so that it can learn the inverse function well. Unlike the traditional autoencoder which uses the
code layer µ̂ to predict the input nodes, the FAE’s decoder employs the known data generating
algorithm x̂ = f(z, µ̂). We built an additional straight connection from the input z node directly
to the final output node x̂, which is an extreme case of the residual neural network, see Figure 2.3.
Two main differences between traditional autoencoder and our FAE are summarized as follows:
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• First, we use the exact data generating algorithm instead of another group of neural network
as the decoder.
• Second, our decoder takes as the input not only code layer µ̂ but also the random component
Z?.
One big advantage of FAE, compared to the usual AE, is that it never suffers a lack of training
data. This is because the training data is obtained by simulation from the data generating algorithm
that is known to us. In particular, given a number of training {µk, k = 1, 2, ..., ntrain}, we could
generate as many pairs of xk and zk for training FAE as needed. The limitation is that we need to
make sure that the training set contains a large enough number of data sets that are similar to the
observed data. For example, if the training set does not contain enough values of µk that are close
to the true µ, we cannot guarantee the FAE to provide good answers. Therefore, we recommend
that enough of the training data is generated using values of µk close to some pilot estimator of µ̂.;
for example, the least square estimator as in Section 2.4.4.
Since the decoder is the fixed deterministic data generating function, the loss of FAE quantifies
how well the encoder approximates the inverse function. The total loss function we use for training
our neural network contains two parts, the mean square error with regard to x̂ and µ̂: L =
w1‖x− x̂‖2 +w2‖µ− µ̂‖2, where w1 and w2 are user-selected weights. If we set w1 = 0 and w2 = 1,
we would in effect be training a neural network mapping directly from X and Z to µ, and we
would miss the information provided by the data generating function. Our numerical experiments
show that this choice is not optimal. After incorporating the information from the data generating
function, the approximation performance is greatly improved. On the other hand, if we only use
the mean square error based on predicting the data, ‖x− x̂‖2 (w1 = 1 and w2 = 0), the FAE would
still do reasonably well. However, using MSE for µ̂ with appropriate weights does not only increase
the convergence speed but also improves the FAE’s performance. In our numerical experiments we
manually select w1, w2 so that the loss with regard to the observation, w1‖x− x̂‖2, and the loss
with regard to the parameter, w2‖µ− µ̂‖2, are roughly of the same magnitude. For example, we
set w1 = w2 = 1 as the default parameters in Section 2.4.2.
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2.3.2 Approximate fiducial computation
Once the FAE converges, we simply apply the encoder with pairs of the fixed observed x and
a number of simulated Z?, which are the independent identical copy of Z, to get the estimated
µ?. Truncating these fiducial samples to the set Z? ∈ Cε, defined in (2.3), using approximate
fiducial computation algorithms, one will achieve samples from the approximate generalized fiducial
distribution that can be used for inference. Notice that using only Z? ∈ Cε is very natural as we
are discarding those Z? for which FAE predicts values of x? that are far from the observed value
x.
This is similar to the approximate Bayesian computation (ABC) that have been intensively
studied in the past years (Blum et al., 2013). Similar to ABC, which is designed to overcome the
intractable likelihood function, AFC avoids directly calculating the fiducial density and the inverse
function. One major difference is that while ABC uses a prior distribution to get candidate µ?, the
AFC algorithm uses the optimization problem (2.2) eschewing the need to select an arbitrary prior
distribution.
The steps of the AFC algorithms are summarized in Algorithm 1. Note that for different
problems and even for different parameters within the same problem we might need to select
different thresholds (ε in equation (2.3)) to efficiently get valid approximate generalized fiducial
samples. If the threshold is too big, then we might get biased samples; if the threshold is too small,
it would be very difficult for AFC to generate enough samples passing the threshold condition. In
practice, we could use one random batch of samples to approximate the distribution of dist(x,x?),
and select the threshold according to the efficiency and the accuracy we expect for the AFC.
We call the samples from Algorithm 1 approximate generalized fiducial samples. Aggregating
those samples into an empirical distribution provides an approximation to the GFD and form the
bases for making statistical inference. In our numerical experiments, we study statistical properties
of the point estimators based on the mean and median, and the α-level approximate confidence
intervals based on the (1 − α)/2 and (1 + α)/2 empirical quantiles of the generalized fiducial
samples. The corresponding confidence curves are reported to visualize the approximate fiducial
distribution. Finally, we remark that the AFC algorithm can be useful even in situations when we
11
know the analytical form of the fiducial inverse function (2.2). We demonstrate this on an example
in Section 2.4.1.
Algorithm 1: Approximate Fiducial Computation (AFC)
Input : Data generating function f; (approximate) inverse function g; distribution F0 for
generating Z?; observation x; threshold ε
Output: Generalized fiducial samples (GFS)
1 while (itr < max itr) and (# of GFS < N) do
2 Sample Z? from F0;
3 µ? = g(x,Z?) ;
4 x? = f(Z?, µ?) ;





10 itr = itr + 1;
11 end
2.4 Simulation
We report the results of four numerical experiments. The first is the location-scale Laplace
distribution, a relatively straightforward example illustrating AFC when the analytical form of
the inverse of the data generating algorithm is available. The second example demonstrates that
FAE can learn a non-linear inverse function and shows how AFC improves the inference with the
decreasing thresholds ε. The third example shows AFC improves the inference of a function of
parameter. The fourth example compares FAE and several competing methods using a highly
non-linear regression model.
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2.4.1 Location-scale Laplace distribution
Consider the data generating algorithm
x = f(z, µ) = θ × 1 + σz,
where x = (x1, . . . , xm)
> are the observed data, µ = (θ, σ) are the unknown scalar parameters,
and z = (z1, . . . , zm)
> is a vector of i.i.d. samples from standard Laplace distribution, i.e., density
f(z) = e−|z|/2. Straightforward calculations show that µ? = (θ?, σ?) = g(x,Z?) is
σ? =
∑m




and θ? = x̄− σ?Z̄?, (2.4)
where x̄ = m−1
∑m






Since we have the analytical solution for the inverse function we can easily compute µ? =
g(x,Z?) for any Z? following Laplace distribution. This is the baseline method without AFC
algorithm. Then we use the data generating algorithm to compute the predicted observation
x? = f(Z?, µ?) = θ? × 1 + σ?Z?, and accept the proposed µ? if and only if ‖x− x?‖ ≤ ε for some
pre-selected threshold ε. This process is repeated until we get the desired number of AFC corrected
fiducial samples.
Notice that for small enough ε the AFC algorithm will not accept Z? that does not match the
order of the data. Since the distribution of Z? is exchangeable, we will without loss of generality
assume that both x1 < · · · < xm and Z?1 < · · · < Z?m are ordered. This will make the algorithm
more efficient. Finally, because of invariance of the location-scale model, it is enough to perform
the simulation using only one value the true parameter value, say θ = 0 and σ = 1.
Figure 2.4 shows an example of CC with and without AFC for the same dataset containing
m = 100 observations. In the left panel, we see that the CC for θ with AFC (orange) is much
thinner than the curve without AFC (blue). And the corresponding fiducial median with AFC
is also more close to the truth 0. In the right panel, the CC for σ with AFC provides a slightly
narrower 90% confidence interval compared with that without AFC.
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Figure 2.4: Confidence curves of marginal distributions for the Laplace example. The red vertical lines
shows the true parameters (θ = 0 and σ = 1) generated the observed data. The yellow horizontal line
indicates the 90% confidence intervals.
Table 2.1: Inference performances without AFC for Laplace example.
Truth Coverage Expected CI Length Expected Mean Expected Median
θ = 0 0.835 0.4468 0.0042 0.0048
σ = 1 0.935 0.3636 0.9717 0.9657
Tables 2.1 and 2.2 compare the inference performance with and without AFC. In particular,
we fixed the true parameters θ = 0 and σ = 1, and observed 200 data sets each containing
m = 100 observations {xk = (x1,k, . . . , xm,k)>, k = 1, . . . , 200}. For each xk, we used 1,000 random
{Z?j,k, j = 1, . . . , 1000} to obtain the corresponding µ?j,k and use them to obtain estimators of the
mean, median and 90% confidence set. We report four key statistics averaged over the 200 data
sets, namely, coverage, the expected length of the confidence intervals, the expected value of the
fiducial mean and median. We can see that AFC provides more accurate point estimations for both
mean estimator and median estimator. In addition, the length of confidence intervals with AFC at
the same confidence level are shorter than those without AFC. Lastly, AFC improves the coverage
for θ and σ.
Table 2.2: Inference performances with AFC for Laplace example.
Truth Coverage Expected CI Length Expected Mean Expected Median
θ = 0 0.870 0.4244 0.0033 0.0032
σ = 1 0.940 0.3466 0.9872 0.9796
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2.4.2 Nonlinear data generating algorithm
Consider the following non-linear model defined by the data generating algorithm
x = µ× 1 + µ
q
2 × z,
where x, z ∈ Rm(m = 3) and µ ∈ R, with zi as the realizations of independent standard normal
random variables. Here, µ is the parameter of interest and q/2 is known. When q = 0, this
becomes a standard location parameter problem: X = µ × 1 + Z, q = 2 is a scale parameter
problem X = µ × (1 + Z). and q = 4 leads to a one-parameter exponential family. In this
numerical experiment we choose q = 3 in order to have a true non-linear model.
To train the FAE, we simulate 100,000 µk from the Uniform(0, 6) distribution and randomly
split them to 80,000 training samples and 20,000 validation samples. These µk serve as the true
parameter for training purposes. We use an 11 layer fully-connected neural network as the encoder
with ReLU as the activation function (Nair and Hinton, 2010) and with Adam as the optimizer
(Kingma and Ba, 2014). The FAE converges after 10 epochs. All FAEs in this chapter are imple-
mented using on Keras in Python (Chollet et al., 2015).
After the FAE has converged we will use the fitted encoder for inference. In particular we
first randomly sample Z?j , j = 1, . . . , nfid (nfid = 1000) and use them together with the observed
data x in the encoder to obtain nfid samples of µ
?
j . Notice that the same observed value of x is
used for all µ?j . Using the µ
?
j we can estimate an empirical distribution function of the GFD for µ
and draw a corresponding confidence curve. Figure 2.5 shows confidence curves for nine different
realizations of x. Most of the confidence intervals are wide and only 7 of 9 true µ are covered by
the corresponding 95% level confidence interval.
Table 2.3 presents the results of a simulation study using FAE without AFC. In particular, we
fixed four true µ ∈ 1, 2, 3, 4, and observed 200 data sets {xk, k = 1, . . . , 200} for each of the four
values of µ. For each xk, we use 1,000 random Z
?
j to obtain µ
?
j and use them to obtain fiducial
mean, median and 90% confidence set. Table 2.3 reports four key statistics averaged over the 200
data sets, namely, coverage, the expected length of the confidence intervals, the expected value of
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Figure 2.5: Nine confidence curves for nonlinear data generating algorithm of FAE without AFC. The red
vertical lines correspond to the true parameters. The intersection of the confidence level (yellow horizontal
line) and the blue confidence curve shows the 95% confidence interval. The values of Z are the random
realizations used in the data generating algorithm.
the fiducial mean and median . We can see that the confidence sets are very wide and the expected
fiducial mean and the expected fiducial median are biased.
Next, we investigate the effect of AFC for a fixed observation. Figure 2.6 shows confidence
curves for the same data x with different thresholds; the true µ = 3.5. As the threshold ε decreases,
the marginal fiducial median is getting closer to the true µ. Additionally, the fiducial distribution
is becoming more concentrated.
Finally, we repeated the simulation study for FAE with AFC to generate 1,000 threshold-
admissible samples to form inference estimates. As shown in Table 2.4, the fiducial mean and
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Table 2.3: Inference performances without AFC for nonlinear data generating algorithm.
True µ Coverage Expected CI Length Expected Mean Expected Median
1 0.985 2.03 1.07 0.90
2 0.905 3.50 2.64 2.49
3 0.865 4.25 3.85 3.81
4 0.870 4.28 4.48 4.45
Figure 2.6: Confidence curves with different thresholds. The red vertical lines correspond to the true
parameter (µ = 3.5).
median with AFC is less biased compared to the inference performance without AFC shown in
Table 2.3. The empirical coverage is greater than the true 90% confidence level for all 4 settings.
Table 2.4: Inference performances with AFC for nonlinear data generating algorithm.
True µ Coverage Expected CI Length Expected Mean Expected Median
1 0.95 3.10 1.44 1.06
2 0.95 4.07 2.55 2.18
3 0.97 3.43 3.22 2.99
4 0.94 3.30 3.98 3.89
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2.4.3 Many means
For this simulation, we are able to calculate the analytical form of the inverse function. We
show the improvement of AFC by comparing the inference performances with and without AFC to
select the valid threshold fiducial samples.
Considering the following data generate equation: x = µ+ z, with x ∈ <m, µ ∈ <m, and z ∈ <m.
And the parameter of interests is the square of the l-2 norm of µ, ‖µ‖2, instead of µ itself. We
will first generated fiducical samples of µ, and further generated admissible ‖µ‖2. For this case,
the inverse function of is simple: µ = g(x, z) = x − z. But when plug in the true x and z∗, an
independent copy of z, into the inverse function g and carried the AFC algorithms, we will accept
every proposed µ, since x̂ = f(µ̂, z∗) = µ̂ + z∗ = g(x, z∗) + z∗ = x − z∗ + z∗ = x. We proposed
the following estimation µ̂ = ‖µ̃‖ ∗ (x/‖x‖) with µ̃ = x− z∗.
Figure 2.7: Confidence curves with and without AFC.
Table 2.5: Inference performances for many means example. (‖µ‖2 = 3.37)
If AFC Coverage Expected CI Length Expected Mean Expected Median
No 0.85 3.12 3.91 3.91
Yes 0.95 3.29 3.65 3.64
As shown in Table 3, the empirical coverage increase 10%, and the expected median and the
expected mean is more accurate with AFC.
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2.4.4 Biological oxygen demand problem
Here we further test our AFC-corrected FAE solution on a non-linear regression algebraic model
for Biological Oxygen Demand (BOD) (Bardsley et al., 2014) . The BOD model is often used for
simulating the saturation of the growth of the observed response y that corresponds to a given
variable x. The corresponding data generating algorithm is
y = f(µ,x) = t0(1− e−t1x) + z (2.5)
where the parameters µ = (t0, t1) are two scalars to estimate; the observed synthetic data have five
design points x = (2, 4, 6, 8, 10) and dependent observations y = (0.152, 0.296, 0.413, 0.482, 0.567).
The observation errors z = (z1, . . . , z5) are assumed to be independent and identically distributed
mean zero Gaussian errors with the standard deviation σ > 0. Following (Bardsley et al., 2014) we
fixed σ = 0.015.
To train the FAE for the BOD model, we simulate 120,000 samples, with 96,000 as training
dataset and 24,000 as validation dataset. Each data frame indexed by k contains three parts, the
parameters µk = (t0,k, t1,k), with t0,k from the Uniform(0.4, 1.2) distribution and t1,k from the
Uniform(0.000001, 0.2) distribution, the random error zk from N5(0, σ
2I5), and the corresponding
yk generated from the data generating algorithm (2.5). Notice that these µk serve as the true
parameter for training purpose and are generated around the least square estimators of the pa-
rameters (t̂0 = 0.90110, t̂1 = 0.09863). Our encoder consists of 8 shared fully-connected layers that
learn code from the observed data (x,yk) and the corresponding zk; then 3 fully-connected layers
map from the code space to t0, and in parallel one fully-connected layer maps from the code to t1.
We use ReLU as the activation function and Adam as the optimizer. The FAE converges after 10
epochs.
We used four different methods to analyze the BOD data with the resulting distributions
reported in Figure 2.8. The FAE with AFC is in panel a); the GFD using Theorem 1 implemented
using Hamiltonian Monte Carlo in STAN (Stan Development Team, 2020) is in panel b); the
parametric bootstrap (Tibshirani and Efron, 1993) is in panel c); and the Bayesian solution of
(Bardsley et al., 2014) using Metropolis-Hastings algorithm with a simplified fiducial-like proposal,
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Figure 2.8: Contour plots of the joint posteriors for the BOD example. (a) FAE estimation with AFC
algorithm (orange); (b) fiducial estimation implemented via HMC (brown); (c) parametric bootstrap (cyan);
(d) RTO (Bayesian) solution (magenta). The red dots near the center of the contours represent the true
parameters (t0 = 0.9, t1 = 0.1) that generated the observed data.
called randomize-then-optimize (RTO), is in panel d). Notice that all methods yield a ”banana-
shaped” distribution centered around the true parameters (t1 = 0.9, t2 = 0.1), indicated by the
red dots in Figure 2.8. The AFC-corrected FAE solution (orange contour) achieve the thinnest
banana-shape among all, while the RTO solution is the widest. Furthermore, we report confidence
curves based on the marginal distributions of the two parameters separately in Figure 2.9. Again
our AFC-corrected FAE solution is the thinnest among the four methods. Both the thinnest banana
shape and confidence curve indicate that our AFC-corrected FAE solution is the most concentrated
near the truth.
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Figure 2.9: Confidence curves of marginal distributions for the BOD example. The colors associated with
the methods are the same as in Figure 2.8. The red vertical lines are the true parameters (t0 = 0.9, t1 = 0.1)
that generated the observed data. The yellow horizontal line indicates the 90% confidence intervals.
In summary, we have shown how to use AFC with and without the analytical form of the
inverse function, and by implementing AFC we improved the inference performances of GFI. Our
FAE provides an accurate approximation of the inverse function.
2.5 Discussion
In this chapter, we first proposed a fiducial autoencoder for the circumstance in which the an-
alytical form of the inverse function is not available or the marginal fiducial density is intractable.
The universal approximation theorem provides theoretical guarantees for the approximation per-
formance of our FAE, and our simulations further validate our approach. The proposed FAE can
accurately approximate the inverse function, and it can be efficiently combined with the AFC algo-
rithm to provide valid and accurate inferences of the true parameters. The AFC algorithm is similar
to ABC and provides an insight into the relationship between Bayesian and fiducial distribution;
the use of a prior versus solving an optimization problem when proposing µ.
For modern machine learning and deep learning communities, data are usually implicitly mod-
eled, while for fiducial inference, we explicitly model the modeling mechanism behind the data
through our data generating algorithm. Under the FAE framework, we are combining those two
approaches: we incorporate the data generating algorithm as a decoder (explicitly model the for-
ward process); we keep deep neural network (implicit model) as an encoder to computationally
solve the inverse problem. Furthermore, FAE might help the deep learning community to under-
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stand the neural work through our fiducial autoencoder. For example, a neural network is often
regarded as a non-linear regression tool, but one main difficulty for DL is that the true function
is unknown. When the inverse function has an analytical solution, we can quantify the biases in
a certain sense. Thus studying the theoretical properties of FAE could potentially be helpful to
understand the neural network.
One limitation of our AFC-corrected FAE solution is that the inference results are sensitive to
the training data FAE learned from. Neural networks are known for their ability to perform well on
the similar data it has seen before. If most of the parameters of our simulated training data are far
from the true parameter of the observed data, or FAE does not see enough similar training data as
the true parameters of the observed data, FAE, even with AFC, might provide a biased estimation.
A simple remedy for that is to generate the training data around the least square estimation of the
parameter. In other words, we only require the FAE to learn the inverse function around the true
parameter, instead of the whole parameter space, which can be much harder.
We have focused on cases with completely known data-generating algorithm and our pre-defined
neural network architecture (fully connected neural networks) in the numerical experiments. The
main purpose of these studies is to demonstrate the approximation performance of the FAE and
the validity of the AFC algorithm. Thus we did not tune the best neural network architecture for
the encoder part of the FAE. Note we do not have a specific requirement for the network structure
of encoder. Any standard deep neural networks can be used to construct an encoder. However, to
learn a complex inverse function inevitably requires a more sophisticated construction of encoder.
This can be a potential issue, but rapid development of deep learning should provide new elegant
architectures that increase the FAE applicability. The competitive performance of AFC corrected




SMNN: Batch Effect Correction for Single-cell RNA-seq data
via Supervised Mutual Nearest Neighbor Detection
3.1 Introduction
An ever-increasing amount of single cell RNA-sequencing (scRNA-seq) data has been gener-
ated as scRNA-seq technologies mature and sequencing costs continue dropping. However, large
scale scRNA-seq data, for example, those profiling tens of thousands to millions of cells (such as
the Human Cell Atlas Project (Rozenblatt-Rosen et al., 2017), almost inevitably involve multiple
batches across time points, laboratories, or experimental protocols. The presence of batch effect
renders joint analysis across batches challenging (Chen and Zhou, 2017; Stegle et al., 2015). Batch
effect, or systematic differences in gene expression profiles across batches, not only can obscure
the true underlying biology, but also may lead to spurious findings. Thus, batch effect correction,
which aims to mitigate the discrepancies across batches, is crucial and deemed indispensable for
the analysis of scRNA-seq data across batches (Stuart and Satija, 2019a).
Because of its importance, a number of batch effects correction methods has been recently pro-
posed and implemented. Most of these methods, including limma (Smyth, 2005), ComBat (Johnson
et al., 2007), and svaseq (Leek, 2014) , are regression-based. Among them, limma and ComBat ex-
plicitly model known batch effect as a blocking term. Because of the regression framework adopted,
standard statistical approaches to estimate the regression coefficients corresponding to the block-
ing term can be conveniently employed. In contrast, svaseq is often used to detect underlying
unknown factors of variation, for instance, unrecorded differences in the experimental protocols.
svaseq first identifies these unknown factors as surrogate variables and subsequently corrects them.
For these regression-based methods, once the regression coefficients are estimated or the unknown
factors are identified, one can then regress out these batch effects accordingly, obtaining residuals
that will serve as the batch-effect corrected expression matrix for further analyses. These methods
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have become standard practice in the analysis of bulk RNA-seq data. However, when it comes to
scRNA-seq data, one key underlying assumption behind these methods, that the cell composition
within each batch is identical, might not hold. Consequently, estimates of the coefficients might
be inaccurate. As a matter of fact, when applied to scRNA-seq data, the corrected results derived
from these methods widely adopted for bulk RNA-seq data might be even inferior to raw data
without no correction, in some extreme cases (Haghverdi et al., 2018).
To address the heterogeneity and high dimensionality of complex data, several dimension-
reduction approaches have been adopted. An incomplete list of these strategies includes principal
component analysis (PCA), autoencoder, or force-based methods such as t-distributed stochastic
neighbor embedding (t-SNE) (Van Der Maaten, 2014). Through those dimension reduction tech-
niques, one can project new data onto the reference dataset using a set of landmarks from the
reference (Haghverdi et al., 2018; Nestorowa et al., 2016; Spitzer et al., 2015; Stuart and Satija,
2019b) to remove batch effects between any new dataset and the reference dataset. Such projection
methods require the reference batch contains all the cell types across batches. As one example,
Spitzer et al. (Spitzer et al., 2015) employed force-based dimension reduction and showed that
leveraging a few landmark cell types from bone marrow (the most appropriate tissue in that it
provides the most complete coverage of immune cell types) allowed mapping and comparing im-
mune cells across different tissues and species. When applied to scRNA-seq data, however, these
methods suffer when cells from a new batch fall out of the space inferred from the reference. Fur-
thermore, determining the dimensionality of the low dimensional manifolds is still an open and
challenging problem. To address the limitations of existing methods, two recently developed batch
effect correction methods, MNN and Seurat v3, adopt the concept of leveraging information of
mutual nearest neighbors (MNN) across batches (Haghverdi et al., 2018; Stuart and Satija, 2019b),
and demonstrate superior performance over alternative methods (Haghverdi et al., 2018; Stuart
and Satija, 2019b). However, this MNN-based strategy ignores cell type information and suffers
from potentially mismatching cells from different cell types/states across batches, which may lead
to undesired correction results. For example, under the scenario depicted in Fig. 3.1b, MNN
leads to cluster 1 (C1) and cluster 2 (C2) mis-corrected due to mismatching single cells in the two
clusters/cell-types across batches.
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To address the above issue, here we present SMNN, a supervised machine learning method that
explicitly incorporates cell type information. SMNN performs nearest neighbor searching within
the same cell type, instead of global searching ignoring cell type labels (Fig. 3.1a). Cell type
information, when unknown a priori, can be inferred via clustering methods (Duò et al., 2018;
Kiselev et al., 2019; Sun et al., 2019; Zhu et al., 2019).
3.2 Methodology
3.2.1 SMNN framework
The motivation behind our SMNN is that single-cell cluster or cell type information has the
potential aid the identification of most relevant nearest neighbors and subsequently improve batch
effect correction. A preliminary clustering before any correction can provide knowledge regarding
cell composition within each batch, which serves as the cellular correspondence across batches (Fig.
3.1a). With this clustering information, we can refine the nearest neighbor searching space within a
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Figure 3.1: Overview of SMNN. Schematics for detecting mutual nearest neighbors between two
batches under a non-orthogonal scenario (a) in SMNN; and (b) in MNN. (c) Workflow of SMNN. Single cell
clustering is first performed within each batch using Seurat v3; and then SMNN takes user-specified marker
gene information for each cell type to match clusters/cell types across batches. With the clustering and
cluster-specific marker gene information, SMNN searches mutual nearest neighbors within each cell type and
performs batch effect correction accordingly.
SMNN takes a natural two-step approach to leverage cell type label information for enhanced
batch effect correction (Fig. 3.1c). First, it takes the expression matrices across multiple batches
as input, and performs clustering separately for each batch. Specifically, in this first step, SMNN
uses Seurat v3 (Butler et al., 2018) where dimension reduction is conducted via principal com-
ponent analysis (PCA) to the default of 20 PCs, and then graph-based clustering follows on the
dimension-reduced data with resolution parameter of 0.9 (Huh et al., 2019; Yang et al., 2019).
Obtaining an accurate matching of the cluster labels across batches is of paramount importance
for subsequent nearest neighbor detection. SMNN requires users to specify a list of marker genes
and their corresponding cell type labels to match clusters/cell types across batches. We hereafter
refer to this cell type or cluster matching as cluster harmonization across batches. Because not
all cell types are necessarily shared across batches, and no prior knowledge exists regarding the
exact composition of cell types in each batch, SMNN allows users to take discretion in terms of the
marker genes to include, representing the cell types that are believed to be shared across batches.
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Based on the marker gene information, a harmonized label is assigned to every cluster identified
across all the batches according to two criteria: the percentage of cells in a cluster expressing a
certain marker gene and the average gene expression levels across all the cells in the cluster. After
harmonization, cluster labels are unified across batches. This completes step one of SMNN. Note
that if users have a priori knowledge regarding the cluster/cell-type labels, the clustering step could
be bypassed completely.
With the harmonized cluster or cell type label information obtained in the first step, SMNN,
in the second step, searches mutual nearest neighbors only within each matched cell type between
the first batch (which serves as the reference batch) and any of the other batches (the current
batch), and performs batch effect correction accordingly. Compared to MNN or Seurat v3, where
the mutual nearest neighbors or anchor cells are searched globally, SMNN identifies neighbors
from the same cell population or state. After mutual nearest neighbors are identified, similar to
MNN, SMNN first computes batch effect correction vector for each identified pair of cells, and
then calculates, for each cell, the cell-specific correction vectors by exploiting a Gaussian kernel to
obtain a weighted average across all the pair-specific vectors with mutual nearest neighbors of the
cell under consideration. The correction vectors obtained from shared cell-types will be applied to
correct all cells including those belonging to batch-specific cell types.
The correction vector obtained from shared cell-types will be applied to correct all the cells,
including the cells in batch-specific clusters. Specifically, for each cell x in the target batch (which
will be corrected), whether it falls into a batch-shared cluster or a batch-specific cluster, SMNN
calculates a cell-specific correction vector using the same formula below. The cell-specific correction
vector ~u for any target cell x is a weighted sum of vector differences ~vml across all identified MNN
pairs (without loss of generosity, we assume m is from the target batch and l from the reference
batch. Note that in SMNN, the two cells m and l in each MNN pair belong to the same cluster/cell-





The Gaussian kernel weights W (x,m) gives higher weights to vector differences (~vml’s) involving
a cell m in closer proximity with the target cell x. The smaller the distance, the larger of the
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weight. Note that a cell m may appear multiple times and contributes to multiple terms in the
weighted sum if it has multiple MNNs identified by our SMNN. Also note that if cell x belongs to
a batch-specific cluster, itself would not contribute to any of the terms because it would not have
any MNNs.
Each cell’s correction vector is further scaled according to the cell’s location in the space
defined by the correction vector, and standardized according to quantiles across batches, in order
to eliminate “kissing effects”. “Kissing effects” refer to the phenomenon that only the surfaces of
cell-clouds across batches are brought in contact (rather than entire clouds fully merged), commonly
observed with näıve batch effect correction, (Haghverdi et al., 2018). At the end of the second step,
SMNN returns the batch-effect corrected expression matrix matrix including all genes from the
input matrix for each batch, as well as the information regarding nearest neighbors between the
reference batch and the current batch under correction. This step is carried out for every batch
other than the reference batch so that all batches are corrected to the same reference batch in the
end.
SMNN is implemented in R, and freely available at https://yunliweb.its.unc.edu/SMNN/
and https://github.com/yycunc/SMNN.
3.3 Simulation
We simulated two scenarios, orthogonal and non-orthogonal, to compare the performance of
MNN and SMNN. The difference between the two scenarios lies in the directions of the true un-
derlying batch effect vectors with respect to those of the biological effects (see details in Section
3.3.3).
3.3.1 Baseline simulation
Our baseline simulation framework, similar to that adopted in the MNN paper, contains two
steps: Firstly, data are initially generated in low (specifically three) dimensional biological space.
Data in each batch independently generated from a Gaussian mixture model to represent a low
dimensional biological space, with each component in the mixture corresponding to one cell type.
Specifically, we considered two batchesXk and Yl, each of which follows a three-component Gaussian
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i=1w1iN (µ1i, I3) , with
∑3
i=1w1i = 1, and w11, w12, w13 ≥ 0, for k = 1, 2, . . . , n1
Yl ∼
∑3
j=1w2jN (µ2j , I3) , with
∑3
j=1w2j = 1, and w21, w22, w23 ≥ 0, for l = 1, 2, . . . , n2
where µ1i is the three-dimensional vector specifying cell-type specific means for the i-th three
cell types in the first batch, reflecting the biological effect; similarly for µ2j ; n1 and n2 is the total
number of cells in the first and second batch, respectively; w1i and w2j are the different mixing
coefficients for the three cell types in the two batches; and I3 is the three dimensional identity
matrix with diagonal entries as ones and the rest entries as zeros. In our simulations, we set
n1 = 1000, n2 = 1100 and
(w11, w12, w13) = (0.3, 0.5, 0.2)
(w21, w22, w23) = (0.25, 0.5, 0.25)
Secondly, we projected the low dimensional data with batch effect to the high dimensional gene
expression space. We mapped both datasets to G = 50 dimensions by linear transformation using
the same random Gaussian matrix P , to simulate high-dimensional gene expression profiles.
X̃k = PXk, for k = 1, 2, . . . , n1
Ỹl = PYl, for l = 1, 2, . . . , n2
P is a G × 3 Gaussian random matrix with each entry simulated from the standard normal
distribution.
3.3.2 Introduction of batch effects
In the MNN paper (Haghverdi et al., 2018), batch effects were directly introduced in the high
dimensional gene expression space. Specifically, a Gaussian random vector b = (b1, b2, . . . , bG)
T was
simulated and added to the second dataset via the following:
XObserved,k = X̃k + ε1,k, for k = 1, 2, . . . , n1
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YObserved,l = Ỹl + b+ ε2,l, for l = 1, 2, . . . , n2
where ε1,k and ε2,l are independent random noises added to the expression of each “gene” for
each cell in the two batches.
In our simulations, we adopted a slightly different approach: we introduced batch effects in the
low dimensional biological space. Specifically, we simulated a bias vector c = (c1, c2, c3)
T in the
biological space:
XObserved,k = X̃k + ε1,k = PXk + ε1,k, for k = 1, 2, . . . , n1
YObserved,l = ˜YSMNN,l + ε2,l = P (Yl + c) + ε2,l = PYl + Pc+ ε2,l, for l = 1, 2, . . . , n2
Our simulation framework can be viewed as a reparametrized version of the model in Haghverdi
et al. (Haghverdi et al., 2018). For each batch effect b of the model in Haghverdi et al. (Haghverdi
et al., 2018), there exist multiple pairs of projection matrix P and vector c such that b=Pc, and
for any vector c in our model, there is a corresponding vector b=Pc given a fixed projection matrix
P. In particular, (b)l = (P c)l =
∑G








. In other words, for any simulated
setting in Haghverdi et al. (Haghverdi et al., 2018), we can find at least one equivalent setting in our
model; and vice versa. Although our simulation framework is largely similar to that in Haghverdi
et al. (Haghverdi et al., 2018), the two differ in the following two aspects:
First, the low-dimensional biological space is three-dimensional in ours and two-dimensional
in Haghverdi et al. (Haghverdi et al., 2018). Second, we introduce batch effects c in low di-
mensional biological space and then projected to high dimensional space, while Haghverdi et al.
(Haghverdi et al., 2018) directly introduce batch effects b in the high dimensional gene expression
space. We made such changes so that we can simulate both the orthogonal and non-orthogonal
scenarios in a more straightforward manner the extent of orthogonality can be controlled. The
orthogonality is defined in the sense that biological differences (that is, mean difference between
any two clusters/cell-types), are orthogonal to those from batch effects. Our framework allows
flexible modeling of the biological effects and batch effects in the same low dimensional biological
space and allow us to control the extent of orthogonality. Specifically, the batch effect c is added
to mean vectors of three cell types in batch 1 to get the mean vectors of three cell types for batch
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2.
µ2i = µ1i + c, for i = 1, 2, 3
Note that (µ1j − µ1i) c = 0, for i 6= j ∈ {1, 2, 3} represents the orthogonal scenario that varia-
tion from batch effect is orthogonal to mean difference between any two clusters/cell-types, and
(µ1j − µ1i) c 6= 0, for i 6= j ∈ {1, 2, 3} in the non-orthogonal case.
3.3.3 The two scenarios
As aforementioned, we considered two scenarios, orthogonal case and non-orthogonal case.
Orthogonality is defined in the sense that biological differences (that is, mean difference between
any two clusters/cell-types), are orthogonal to those from batch effects.
Leveraging the simulation framework described before (Section 3.3.2), we simulated two sce-
narios via the following:
a) In the orthogonal case, we set c = (0, 0, 2)T
µ11 = (5, 0, 0)
T , µ12 = (0, 0, 0)
T , µ13 = (0, 5, 0)
T
µ21 = (5, 0, 2)
T , µ22 = (0, 0, 2)
T , µ23 = (0, 5, 2)
T
b) In the non-orthogonal case, we set c = (0, 5, 2)T
µ11 = (5, 0, 0)
T , µ12 = (0, 0, 0)
T , µ13 = (0, 5, 0)
T
µ21 = (5, 5, 2)
T , µ22 = (0, 5, 2)
T , µ23 = (0, 10, 2)
T
3.3.4 Performance evaluation
MNN and SMNN share the goal to correct batch effects. Mathematically, using the notations
introduced in Section 3.3.2, the goal translates into de-biasing vector c (which would be effec-
tively reduced to b in the orthogonal case). Without loss of generality and following MNN, we
treated the first batch as the reference and corrected the second batch YObserved,l : l = 1, . . . , n2 to
the first batch XObserved,k : k = 1, . . . , n1. Denote the corrected values from MNN and SMNN as{








To measure the performance of the two correction methods, we utilize the Frobenius norm to
define the loss function:
L(Ŷ , Ỹ ) = ‖Ỹ − Ŷ ‖F =
√√√√ n2∑
l=1






Note that Ỹ is the simulated true profiles (from section 3.3.1) before batch effects and noises
are introduced in section 3.3.2. Since MNN conducts a cosine normalization to the input and the
output, we use cosine-normalized Ỹ when calculating the above loss function.
3.3.5 Simulation results
Since MNN has been shown to excel alternative methods (Haghverdi et al., 2018; Stuart and
Satija, 2019a) , we here focus on comparing our SMNN with MNN. We first compared the per-
formance of SMNN to MNN in simulated data. In our simulations, SMNN demonstrates superior
performance over MNN under both orthogonal and non-orthogonal scenarios (Fig. 3.2 - Fig. 3.6).
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Figure 3.2: Heatmap of gene expression matrices for simulated data under orthogonal scenario.
(a), (b), (c) and (d) show the 3-dimensional biological space with rows of each heatmap representing biological
factors and columns corresponding to single cells. (e), (f), (g) and (h) show the high dimensional gene
expression profiles with rows corresponding to genes and columns again representing single cells. (a), (e) and
(i) correspond to the batch 1, and (b), (f) and (j) correspond to batch 2. (c) and (g) provide a visualization
for the direction of batch effects in low-dimension biological space and high-dimension gene expression spaces,
respectively. (d) and (h), sum of (b) and (c) and sum of (f) and (g) respectively, are “observed” data for
cells in batch 2 in low and high dimensional space respectively. (i) and (j) are the cosine-normalized data
for batch 1 and original batch 2. Note “original” is in the sense that no batch effects have been introduced
to the data yet. (k) and (l) are the MNN and SMNN corrected results, respectively.
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Figure 3.3: Heatmap of gene expression matrices for simulated data under non-orthogonal
scenario. (a), (b), (c) and (d) show the 3-dimensional biological space with rows of each heatmap
representing biological factors and columns corresponding to single cells. (e), (f), (g) and (h) show the high
dimensional gene expression profiles with rows corresponding to genes and columns again representing single
cells. (a), (e) and (i) correspond to the batch 1, and (b), (f) and (j) correspond to batch 2. (c) and (g)
provide a visualization for the direction of batch effects in low-dimension biological space and high-dimension
gene expression spaces, respectively. (d) and (h), sum of (b) and (c) and sum of (f) and (g) respectively,
are “observed” data for cells in batch 2 in low and high dimensional space respectively. (i) and (j) are the
cosine-normalized data for batch 1 and original batch 2. Note “original” is in the sense that no batch effects
have been introduced to the data yet. (k) and (l) are the MNN and SMNN corrected results, respectively.
We show t-SNE plot for each cell type before and after MNN and SMNN correction under
both the orthogonal and non-orthogonal scenarios. Under orthogonality, the two batches partially
overlapped in the t-SNE plot before correction, suggesting that the variation due to batch effect
was indeed much smaller than that due to biological effect. Both MNN and SMNN successfully
mixed single cells from two batches (Fig. 3.4). However, for cell types 1 and 3, there were still some
cells from the second batch left unmixed with those from the first batch after MNN correction (Fig.
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3.4a and c). Under the non-orthogonal scenario, the differences between two batches were more
pronounced before correction, and SMNN apparently outperformed MNN (Fig. 3.5), especially in































































































































































Figure 3.4: t-SNE plots by cell type under the orthogonal scenario. The first column shows the
uncorrected data after cosine normalization; the second column shows the MNN corrected results and the







































































































































































Figure 3.5: t-SNE plots by cell type under the non-orthogonal scenario. The first column shows
the uncorrected data after cosine normalization; the second column shows the MNN corrected results and
the last column shows the SMNN corrected results. (a), (b) and (c) corresponds to three different cell types.
Moreover, we also computed Frobenius norm distance (Van Loan and Golub, 1983) for each
cell between its simulated true profile before introducing batch effects and after SMNN and MNN
correction. The results showed an apparently reduced deviation from the truth after SMNN correc-
tion than MNN (Fig. 3.6). We have also simulated data using the original simulation framework in
Haghverdi et al. (Haghverdi et al., 2018), which does not allow precise control of orthogonality and
seems to simulate data closer to those under orthogonal cases (Appendix B: Fig. B.1a). Applying
SMNN and MNN to such simualted data, we also found that SMNN showed slight advantages (Ap-
pendix B: Fig. B.1b) These results suggest that SMNN provides improved batch effect correction
over MNN under both orthogonal and non-orthogonal scenarios.
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Figure 3.6: Frobenius norm distance between two batches after SMNN and MNN correction in simulation
data under orthogonal (left) and non-orthogonal scenarios (right).
3.4 Real data benchmarking
To assess the performance of SMNN in real data, we first compared SMNN to alternative batch
effect correction methods: MNN (Haghverdi et al., 2018), Seurat v3 (Butler et al., 2018), and
LIGER (Welch et al., 2019) on two hematopoietic scRNA-seq datasets, generated using different
sequencing platforms, MARS-seq and SMART-seq2 (Table 3.1) (Nestorowa et al., 2016; Paul et al.,
2015). The first batch produced by MARS-seq consists of 1920 cells of six major cell types, and
the second batch generated by SMART-seq2 contains 2730 of three cell types, where three cell
types, CMP, GMP and MEP cells, are shared between these two batches (here the two datasets).
Batch effect correction was carried out using all four methods, following their default instructions.
Cell type labels were fed to SMNN directly according to the annotation from the original papers.
To better compare the performance between MNN and SMNN, only the three cell types shared
between the two batches were extracted for our downstream analyses. The corrected results of all
the three cell types together, as well as for each of them separately, were visualized by UMAP using
umap-learn method (McInnes et al., 2018). In order to qualify the mixture of single cells using
both batch correction methods, we calculated: 1) F statistics under two-way multivariate analysis
of variance (MANOVA) for merged datasets of the two batches. F statistics quantifies differences
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between batches, where smaller values indicating better mixing of cells across batches; and 2) the
distance for the cells within each cell type in batch 2 to the centroid of the corresponding cell group
in batch 1.
To measure the separation of cell types after correction, we additionally attempted to detect
differentially expressed genes (DEGs) between different cell types in both SMNN and MNN cor-
rected datasets. The corrected expression matrices of the two batches were merged and DEGs were
detected by Seurat v3 using Wilcoxon rank sum test (Butler et al., 2018). Genes with an adjusted
p-value < 0.01 were considered as differentially expressed. Gene ontology (GO) enrichment analysis
was performed for the DEGs exclusively identified by SMNN using clusterProfiler (Yu et al., 2012).
Because there is no ground truth for DEGs, we further identified DEGs between different cell types
within corrected batch 2 and then compared them to those identified in uncorrected batch 1 and
uncorrected batch 2, which supposedly are not affected by the choice of batch effect correction
method. Precision was computed for each comparison. Furthermore, we performed batch effect
correction on another two tissues/cell lines, pancreas (Grün et al., 2016; Muraro et al., 2016) human
peripheral blood mononuclear cells (PBMCs) (Zheng et al., 2017), again using both SMNN and
MNN. DEGs were detected between T cells and B cells in the merged PBMC and T cell datasets
after SMNN and MNN correction, respectively. Furthermore, single cell clustering was applied to
batch-effects corrected gene expression matrices in all the three real datasets following the pipeline
described in MNN paper (Haghverdi et al., 2018). Cell type labels before correction were consid-
ered as ground truth and Adjusted Rand Index (ARI) (Hubert and Arabie, 1985) was employed to
measure the clustering similarity before and after correction:






































where nq and ns are the single cell numbers in cluster q and s, respectively; nqs is the number of
single cells shared between clusters q and s; and n is the total number of single cells. ARI ranges
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from 0 to 1, where a higher value represents a higher level of similarity between the two sets of
cluster labels.
Figure 3.7: Performance comparison between SMNN and MNN in two hematopoietic datasets.
(a) UMAP plots for two hematopoietic datasets before batch effect correction. Solid and inverted triangle
represent the first and second batch, respectively; and different cell types are shown in different colors. (b-e)
UMAP plots for the two hematopoietic datasets after correction with MNN, Seurat v3, LIGER, and SMNN.
(f) Logarithms of F-statistics for merged data of the two batches.
For performance evaluation on two hematopoietic datasets using four methods: our SMNN,
published MNN, Seurat v3 and LIGER. Fig. 3.7a-e shows UMAP plot before and after correc-
tion. Notably, all four methods can substantially mitigate discrepancy between the two datasets.
Comparatively, SMNN better mixed cells of the same cell type across batches than the other three
methods, and seemed to better position cells from batch-specific cell types with respect to other
biologically related cell types (Fig. 3.11), especially for common myeloid progenitor (CMP) and
megakaryocyte-erythrocyte progenitor (MEP) cells, which were wrongly corrected by MNN due to
















































Figure 3.8: Quantification of cell-type mismatching in MNN identified nearest neighbors.
(a) Histogram of the proportion of nearest neighbors from a mismatching cell type (for each cell), for two
hematopoietic datasets. (b) Histogram of the proportion of nearest neighbors from a mismatching cell type
(for each cell), for the 10X Genomics datasets. (c) Histogram of the angles (surrogate for orthogonality) for
the 10X Genomics datasets.
Correspondingly, SMNN corrected data exhibits the lowest F value than that from the other
three methods. Specifically, F value is with reduced by 81.5 - 96.6% on top of MNN, Seurat
v3, and LIGER, respectively (Fig. 3.7f). Furthermore, we compared the distance for the cells
between batch 1 and 2, and found that, compared to data before correction, both MNN and SMNN
reduced the Euclidean distance between the two batches (Fig. 3.9). In addition, SMNN further
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decreased the distance by up to 8.2% than MNN (2.8%, 4.3% and 8.2% for cells of type CMP,
MEP and granulocyte-monocyte progenitor (GMP) cells, respectively). ). Under scenarios where
we only have partial cell type information, SMNN still better mixed cells of the same cell type
across batches (detailed in Appendix B; Appendix B: Fig. 3.10a-c and e-g), and manifested the
best/lowest F values, compared with uncorrected and MNN-corrected data (Appendix B: Fig. 3.10d
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Figure 3.9: Boxplot of distances by cell type. For each of the three different cell types, CMP (a),
GMP (b) and MEP (c), we calculate the distance for every cell in batch 2 to its corresponding centroid in
batch1.
3.4.1 SMNN identifies differentially expressed genes that are biologically rele-
vant
We then compared the DEGs among different cell types identified by SMNN and MNN. After
correction, in the merged hematopoietic dataset, 1012 and 1145 up-regulated DEGs were identified
in CMP cells by SMNN and MNN, respectively, when compared to GMP cells, while 926 and 1108
down-regulated DEGs were identified by the two methods, respectively (Fig. B.1a and Appendix
Fig. B.4a). Of them, 736 up-regulated and 842 down-regulated DEGs were shared between SMNN
and MNN corrected data. GO enrichment analysis showed that, the DEGs detected only by SMNN
were overrepresented in GO terms related to blood coagulation and hemostasis, such as platelet
activation and aggregation, hemostasis, coagulation and regulation of wound healing (Fig. B.1b).
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Similar DEG detection was carried out to detect genes differentially expressed between CMP and
MEP cells. 181 SMNN-specific DEGs were identified out of the 594 up-regulated DEGs in CMP cells
when compared to MEP cells (Fig. B.1c), and they were found to be enriched for GO terms involved
in immune cell proliferation and differentiation, including regulation of leukocyte proliferation,
differentiation and migration, myeloid cell differentiation and mononuclear cell proliferation (Fig.
B.1d). Lastly, genes identified by SMNN to be up-regulated in GMP when compared to MEP cells,
were found to be involved in immune processes; whereas up-regulated genes in MEP over GMP
were enriched in blood coagulation (Appendix Fig. B.4e-h). Comparatively, the GO terms enriched
for MNN-specific DEGs seem not particularly relevant to corresponding cell functions (Fig. B.5).
These cell-function-relevant SMNN-specific DEGs indicate SMNN can maintain some cell features
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Figure 3.10: Comparison of differentially expressed genes (DEGs), identified in the merged
dataset by pooling batch 1 data with batch 2 data after SMNN and MNN correction. (a)
Overlap of DEGs up-regulated in CMP over GMP after SMNN and MNN correction. (b) Feature enriched
GO terms and the corresponding DEGs up-regulated in CMP over GMP. (c) Overlap of DEGs up-regulated
in CMP over MEP after SMNN and MNN correction. (d) Feature enriched GO terms and the corresponding
DEGs up-regulated in CMP over MEP.
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In addition, we considered two sets of “working truth”: first, DEGs identified in uncorrected
batch 1; second DEGs identified in batch 2, and we compared SMNN and MNN results to both
sets of working truth. The results showed that, in both comparisons (one comparison for each set
of working truth), fewer DEGs were observed in SMNN-corrected batch 2, but higher precision and
lower false negative rate in each of the three cell types than those in MNN results. When compared
to the uncorrected batch 1, 3.6% - 841% improvements in precision were observed in SMNN results
than MNN (Fig. 3.11 and Appendix Fig. B.7). Similarly, SMNN increased the precision by 6.2%
- 54.0% on top of MNN when compared to uncorrected batch 2 (Appendix Fig. B.6-B.8). We also
performed DEG analysis at various adjusted p-value thresholds and the results showed that the
better performance of SMNN is not sensitive to the p-value cutoff we used for DEG detection. Such
an improvement in the accuracy of DEG identification indicates that higher amount of information





































Figure 3.11: Reproducibility of DEGs (between CMP and GMP), identified in uncorrected
batch 1 and in SMNN or MNN-corrected batch 2. (a) Reproducibility of DEGs up-regulated in CMP
over GMP, detected in batch 1, versus SMNN (left) or MNN-corrected (right) batch 2. (b) Precision of the
DEGs (between CMP and GMP) identified in batch 2 after SMNN and MNN correction. (c) Reproducibility
of DEGs up-regulated in GMP over CMP, identified in the uncorrected batch 1, and in SMNN (left) or
MNN-corrected (right) batch 2. (d) Precision of the DEGs up-regulated in GMP over CMP identified in
batch 2 after SMNN and MNN correction.
We also identified DEGs between T cells and B cells in the merged PBMC and T cell datasets
after SMNN and MNN correction, respectively. Compared to B cells, 3213 and 4180 up-regulated
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DEGs were identified in T cells by SMNN and MNN, respectively, 2203 of which were shared
between the two methods (Appendix Fig. B.10e). GO enrichment analysis showed that, the
SMNN-specific DEGs were significantly enriched for GO terms relevant to the processes of immune
signal recognition and T cell activation, such as T cell receptor signaling pathway, innate immune
response-activating signal transduction, cytoplasmic pattern recognition receptor signaling pathway
and regulation of autophagy (Appendix Fig. B.10f). In B cells, 5422 and 3462 were found to be
up-regulated after SMNN and MNN correction, where 2765 were SMNN-specific (Appendix Fig.
B.10g). These genes were overrepresented in GO terms involved in protein synthesis and transport,
including translational elongation and termination, ER to Golgi vesicle-mediated transport, vesicle
organization and Golgi vesicle budding (Appendix Fig. B.10h). These results again suggest that
SMNN more accurately retains or rescues cell features after correction.
3.4.2 SMNN more accurately identifies cell clusters
Table 3.1: Major characteristics of the three benchmarking datasets.
Dataset Batch ID Tissue Num. of Technical Ref
origin cells platform
Hematopoiesis
batch 1 Mouse 2,729 MARS-seq Paul et al. 2015
hematopoiesis
batch 2 Mouse 1,920 SMART-seq2 Nestorowa et al. 2016
hematopoiesis
Pancreas
batch 1 Human cadaveric 1,007 CEL-seq Grün et al. 2016
pancreata
batch 2 Human cadaveric 1,595 CEL-seq2 Muraro et al. 2016
pancreata
Droplet
batch 1 PBMC 68,580 10X Genomics Zheng et al. 2017
GemCode
batch 2 T Cells 4,459 10X Genomics Zheng et al. 2017
GemCode
Finally, we examined the ability to differentiate cell types after SMNN and MNN correction in
three datasets (Table 3.1). In all three real datasets, ARI after SMNN correction showed 7.6 - 42.3%
improvements over that of MNN (Fig. 3.12), suggesting that SMNN correction more effectively














Figure 3.12: Clustering accuracy in three datasets after batch effect correction. Adjusted
Rand Index (ARI) is employed to measure the similarity between clustering results before and after batch
effect correction.
3.5 Discussion
In this study, we present SMNN, a batch effect correction method for scRNA-seq data via
supervised mutual nearest neighbor detection. Our work is built on the recently developed method
MNN, which has showed advantages in batch effect correction than existing alternative methods.
On top of MNN, our SMNN relaxes a strong assumption that underlies MNN: that the biological
differentiations are orthogonal to batch effects (Haghverdi et al., 2018). When this fundamental
assumption is violated, especially under the realistic scenario that the two batches are rather
different, MNN tends to err when searching nearest neighbors for cells belonging to the same
biological cell type across batches. Our SMNN, in contrast, explicitly considers cell type label
information to perform supervised mutual nearest neighbor matching, thus empowered to extract
only desired neighbors from the same cell type.
A notable feature of our SMNN is that it can detect and match the corresponding cell popula-
tions across batches with the help of feature markers provided by users. SMNN performs clustering
within each batch before merging across batches, which can reveal basic data structure, i.e. cell
composition and proportions of contributing cell types, without any adverse impact due to batch
effects. Cells of each cluster are labeled by leveraging their average expression levels of certain
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marker(s), thus enabling us to limit the mutual nearest neighbor detection within a smaller search
space (i.e., only among cells of the same or similar cell type or status). This supervised approach
eliminates the correction biases incurred by pairs of cells wrongly matched across cell types. We
benchmarked SMNN together with three state-of-the-art batch effect correction methods, MNN,
Seurat v3 and LIGER, on simulated and three published scRNA datasets. Our results clearly
show the advantages of SMNN in terms removing batch effects. For example, our results for the
hematopoietic datasets show that SMNN better mixed cells of all the three cell types across the
two batches (Fig. 3.7a-e), and reduced the differentiation between the two batches by up to 96.6%
on top of the corrected results from the three unsupervised methods (Fig. 3.7f), demonstrating
that our SMNN method can more effectively mitigate batch effect. Additionally, cell population
composition also can be a critical factor in batch effect correction (Fig. B.11). Our results by ana-
lyzing batches with varying cell type compositions suggest that our SMNN is robust to differential
cell composition across batches.
More importantly, the wrongly matched cell pairs may wipe out the distinguishing features of
cell types. This is mainly because, for a pair of cells from two different cell types, the true biological
differentiations between them would be considered as technical biases and subsequently removed
in the correction process. Compared to MNN, SMNN also appears to more accurately recover
cell-type specific features: clustering accuracy using SMNN-corrected data increases substantially
in all the three real datasets (by 7.6 to 42.3% when measured by ARI) (Fig. 3.12). Furthermore, we
observe power enhancement in detecting DEGs between different cell types in the data after SMNN
correction than MNN (Fig. 3.10 and 3.11 and Appendix Fig. B.4-B.8). Specifically, the precision
of the DEGs identified by SMNN were improved by up to 841% and 54.0% than those by MNN
when compared to the two set of working truth, respectively (Fig. 3.11c and d and Appendix Fig.
B.7-B.8). Moreover, GO term enrichment results show that, the up-regulated DEGs identified only
in SMNN-corrected GMP and MEP cells were involved in immune process and blood coagulation,
respectively (Appendix Fig. B.4f and h), which accurately reflect the major features of these two
cell types (Lieu and Reddy, 2012). Similarly, DEGs identified between T and B cells after SMNN
correction are also biologically more relevant than those identified after MNN correction (Fig.
B.10). These results suggest that SMNN can eliminate the overcorrection between different cell
types and thus maintains more biological features in corrected data than MNN. Efficient removal of
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batch effects at reduced cost of biological information loss, manifested by SMNN in our extensive
simulated and real data evaluations, empowers valid and more powerful downstream analysis.
In summary, extensive simulation and real data benchmarking suggest that our SMNN can
not only better rescue biological features and thereof provide improved cluster results, but also
facilitate the identification of biologically relevant DEGs. Therefore, we anticipate that our SMNN




CUE: CpG impUtation Ensemble
for DNA Methylation Imputation Across Platforms
4.1 Introduction
DNA methylation of cytosine residues at CpG dinucleotides is one of the most extensively
studied epigenetic marks. Rich recent literature provides evidence regarding its important role
not only in normal development but also in risk and progression to many diseases (Bird, 2002;
Gonzalo, 2010; Joubert et al., 2016; Klutstein et al., 2016; Iurlaro et al., 2017; Horvath and Raj,
2018; Turecki and Meaney, 2016; Bakusic et al., 2017). A wide range of biological processes are
dependent on DNA methylation status, including gene transcription, X-chromosome inactivation,
cell differentiation, cancer progression and other critical life events or processes such as aging (Bird,
2002; Gonzalo, 2010). Therefore, studying DNA methylation is of great interest and importance.
However, such studies also provide great challenges for a number of reasons including but not
limited to the following four. First, as an epigenetic marker, DNA methylation level is dynamic,
varying over time, across different molecular environment, in different developmental stages, or
across different tissues or cell lines. Second, correlation of methylation levels between CpG sites
decreases dramatically with distance, for example typically < 0.5 when two CpG sites are merely
>500bp apart. Third, there are multiple options to measure DNA methylation (see section 2 for a
more detailed review). Lastly, even using the same measurement technology, batch effect and/or
various other technical biases and noises are almost inevitable (Bird, 2002; Gonzalo, 2010).
With the emergence of powerful technologies such as DNA methylation microarray (Bibikova
et al., 2011b) and bisulfite sequencing, geneticists are able to profile DNA methylation at increas-
ingly higher resolutions. Taking methylation microarrays for an example, we have witnessed new
platforms replacing old ones every few years (Moran et al., 2016; Bibikova et al., 2009; Dedeur-
waerder et al., 2014). However, different platforms (for example, the widely used Illumina Human-
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Methylation27, HumanMethylation450, MethylationEPIC BeadChips) target different CpG sites
and have different marker densities. In addition, different biochemical or experimental techniques
can be used to quantify methylation levels (e.g., type-I versus type-II assays adopted by the Illu-
mina methylation arrays), further hindering joint analysis of data from multiple platforms. Two
aforementioned microarrays, the Illumina HumanMethylationEPIC (HM850) BeadChip and Hu-
manMethylation450 (HM450) BeadChip, are the most commonly used microarrays to measure DNA
methylation levels. While HM450 investigates 485, 577 probes spanning 96% of CpG islands and
92% of CpG shores across a moderate number of genes (Bibikova et al., 2011b) , HM850 provides
much more comprehensive coverage with the additional 413, 743 CpG sites located farther outside
CpG islands. Because HM450 is no longer commercially available, we start to encounter data gen-
erated from a mixture of two different arrays. Such data have largely constrained joint analysis,
where investigators typically focus on the probes shared between the two platforms. This is a
prudent and convenient approach, without having to reevaluate all samples using HM850 (which
is not only time consuming but also cost prohibitive). However, such an approach implies an un-
fortunate waste of HM850 data where more than 40% of data will not be used. In this study, we
present CUE, CpG imputation Ensemble, an ensemble learning framework which leverages several
machine learning algorithms and traditional statistical models, to efficiently utilize data generated
from different platforms. While several existing methods designed for imputing sequencing-density
methylation levels require hundreds of genomic features (e.g., those from the ENCODE project)
to impute each missing CpG methylation site, we consider a relatively simple and more widely-
applicable imputation regime where we only require methylation measurements from the HM450
BeadChip.
Because of the practical needs of imputation in DNA methylation data as well as the success of
imputation methods in other genetic settings, a number of DNA methylation imputation methods
has been proposed in the recent literature. Among them, support vector machines (SVM) and
hybrid of SVM and other models predominated the DNA methylation imputation literature (Bhasin
et al., 2005; Das et al., 2006; Bock et al., 2006; Fang et al., 2006; Zhou et al., 2012; Zhou and Tuck,
2007; Liu et al., 2015).Most of these methods assumed that methylation status is binary. In other
words, a CpG site is either methylated or unmethylated for an individual and thus imputation
becomes a classification problem. Almost all methods proposed prior to 2014 predicted the average
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methylation status for genomic regions, where each region encompasses multiple CpG sites (Zhang
et al., 2015). All of the studies reported accuracy exceeding 90%.
Dichotomizing methylation status, adopted by these SVM based methods, is not ideal in that it
can lead not only to general information loss but also to losing biologically meaningful information
carried by intermediate raw beta values (β). Beta value is the ratio of intensities between methylated
and unmethylated alleles, one standard quantitative measure of DNA methylation levels. β values
range from 0 to 1 with 0 being completely unmethylated and 1 completely methylated. With the
prospering data science field, especially in areas such as machine learning and particularly deep
learning (Bengio, 2009), several algorithms have been successfully employed and reported (see table)
to outperform the earlier SVM based methods. For example, Zhang et al. (Zhang et al., 2015)
in 2015 employed a random forest (RF) classifier to predict methylation levels with five groups
of features selected from the ENCODE Project, achieving 96% accuracy. For another example,
Angermueller et al. (Angermueller et al., 2017) in 2017 adopted a deep learning method to provide
an accurate prediction of single-cell DNA methylation states, which achieved performances similar
to the previous SVM or RF based methods. In the same year, BoostMe (Zou et al., 2018), based
on the state-of-the-art boosting algorithm XGBoost, achieved the same level of accuracy as RF,
but is computationally much more efficient.
In this study, we aim to impute an HM450 dataset up to an HM850 dataset, for increased
coverage of this epigenomic landscape. We first seek solutions among the imputation methods
in previous literatures. Our goal was to develop a general imputation framework to leverage the
merits of different models and improve the imputation accuracy. We also examined the imputation
results and filtering out the low-quality probes. These accurately imputed methylation values
could subsequently improve power in downstream analysis, for example for associating methylation
profiles with the phenotypic trait(s) of interest, widely referred to as epigenome wide association
studies (EWAS).
4.2 Materials (data)
Recent advances in methylation microarrays and sequencing technologies have enabled us to
gauge DNA methylation profiles genome-wide at single base-pair resolution (Laird, 2010). There are
50
four major types of DNA methylation data commonly generated by different technologies (Laird,
2010).
a) Whole-genome bisulfite sequencing (WGBS) data This is the current gold standard for quanti-
fying single-site DNA methylation levels across the genome. WGBS can theoretically quantify
DNA methylation levels at 26 million (out of 28 million in total) CpG sites for the human
genome (Laurent et al., 2010; Lister et al., 2011; Sandoval et al., 2011). The number of CpG
sites measured by WGBS by far exceeds that of the remaining three methods to be reviewed.
Despite its most comprehensive coverage, WGBS is not the standard practice mainly because of
its prohibitively high costs and partly also because of various experimental biases such as those
induced by bisulfite conversion. In addition, WGBS is difficult to apply to a particular region(s)
of interest.
b) Methylation microarrays data The Illumina HumanMethylation27 and HumanMethylation450
BeadChip have been most widely used to measure DNA methylation levels at preselected CpG
sites across the genome. They assay 28,000 and 480,00o CpG sites respectively. The lat-
est Illumina MethylationEpic BeadChip encompasses over 850,000 sites, offering even broader
coverage of the human methylome.
c) Methylated DNA immunoprecipitation sequencing data Generating this type of data is not only
expensive but also experimentally difficult. For example, antibodies to pool down methylated
DNA segments with high sensitivity and specificity are largely non-existing (Bryk et al., 2002;
Ruike et al., 2010; Down et al., 2008).
d) Reduced representation bisulfite sequencing (RRBS) data Combining restriction enzyme diges-
tion and bisulfite conversion, RRBS targets certain regions of the genome by enriching for areas
with a high CpG content (Meissner et al., 2005).
For our ensemble imputation model, We analyzed data from two population cohorts measured
both by both HumanMethylationEPIC (HM850) and HumanMethylation450 (HM450) BeadChip:
the Extremely Low Gestational Age Newborns (ELGAN) study (Santos et al., 2019)(n = 127) and
the Posttraumatic Stress Disorder (PTSD) genetics data repository (Logue et al., 2017) (n = 144).
We assess three datasets: ELGAN and PTSD separately, and a combined dataset with batch ef-
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fects corrected via the ComBat R function. Samples from the PTSD genetics repository were from
the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation
Research and Development National Center for TBI Research at VA Boston Healthcare System.
Informed consent was obtained from all PTSD subjects at the time of study inclusion. ELGAN
study enrolled infants born < 28 weeks of gestion during 2002-2004, in five states and 14 hospitals
in the United states (Santos et al., 2019). Detailed procedure regarding sample recruitment, main
characteristics of study samples, and methylation measurements are presented in previous publi-
cations: Logue el al. for PTSD (Logue et al., 2017) and Hudson et al. for ELGAN (Santos et al.,
2019).
The data used in this study have been pre-preprocessed previously. Logue el al. have previously
published on the 145 samples measured both by HM450 and HM850 (Logue et al., 2017). The
PTSD dataset was first corrected for the individual-level background noise by used GenomeStudio
and then cleaned with the CpGassoc package and the ChAMP package in R (Team, 2008). The
detailed data cleaning and processing of PTSD dataset can be referred to Mark’s paper. In this
dissertation, we further excluded 1 sample and keep 144 complete samples due to its missing of a lot
of probes. Additionally, 127 subjects from ELGAN study (Santos et al., 2019) were selected based
on the availability of placental samples with DNA methylation data by both HM450 and HM850.
DNA methylation data for ELGAN dataset are first pre-processed by minfi package (Aryee et al.,
2014). Then functional normalization is used for background subtraction and dye normalization.
Hudson et al. finally used ComBat function from sva package to adjust for batch effects from two
platforms (Johnson et al., 2007). The detailed placenta tissue collection and other assessments of
DNA methylation for ELGAN dataset can be referred to Hudson’s paper.
We aim to impute HM450 up to HM850, for increased coverage of this epigenomic landscape.
To make our data better follow a Gaussian distribution (PFR model assumption) (Network, 2012,
2015), we employ M values, defined as




instead of the raw beta (β) values. Again, beta values are the ratios of intensities of the methylated
probes over unmethylated probes.
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Since imputing sporadic missing data is not the focus of our work, we removed all probes with
any missing values for convenience. One could apply methods similar to those developed for gene
expression data (Troyanskaya et al., 2001; Bø et al., 2004; Kim et al., 2006; Liew et al., 2010) to
impute the sporadic missing values at directly assayed CpG sites. After removing sporadic missing
values, we further filtered the probes to keep the common complete (no missing data) probes
shared between two cohorts, which would make the assessments of different imputation models on
two cohorts comparable. This left us 248,421 probes for HM450 and 587,454 probes for HM850 for
ELGAN and PTSD cohort respectively. We used 248K as explanatory variables while the 339K
HM850 specific probes as response variables.
4.3 Methodology
4.3.1 Penalized functional regression
Here we present a penalized functional regression model (Goldsmith et al., 2011) with minor
modifications. We also observe Xi(t), indexed by Ti = t representing sample-specific density
function of the DNA methylation levels measured by HM450. Previous work has been shown
that by incorporating non-local density information we could improve the imputation accuracy.




Xi(t)β(t)dt+ Ziγ + εi
with β(t) ∈ L2[0, 1] characterizes the effect of density function Xi(t) when Ti = t. α is the grand
mean and γ denotes the vector of regression coefficients corresponding to the vector of covariates





Estimation of Xi(t): In order to improve imputation accuracy, we incorporated functional
predictors Xi(t) into our model to capture methylome-wide information, besides methylation levels
from local probes encapsulated in Zi. According to the probe’s relative location to a CpG island,
we first defined five groups: “CpG Island,” “North Shore,” “South Shore,” “North Shelf,” and
“South Shelf” (Bibikova et al., 2011a) (Fig. 4.1).
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Then, we estimated the DNA methylation function Xi(t) for a particular target probe using
the DNA methylation data from all HM450 probes falling in the same group as the target probe.
Assuming that probes with similar properties tend to have similar methylation profiles, we use
Xi(t) to borrow information from the nonlocal probes falling in the same group. The observed
DNA methylation data in group g are denoted as τ gi = (τ
g
1 , . . . , τ
g
q ), where q is the number of CpG
sites falling into group g, and τ gj is the DNA methylation value at jth HM450 probe in group g
with j = 1, . . . , q. Rather than estimating Xi(t) by expanding into the principal component basis
obtained from its covariance matrix (Goldsmith et al., 2011), we employed kernel density estimation
to obtain Xi(t) with τ
g
i so that it is specific to group g.
Figure 4.1: Five groups of CpG sites according to their relative location to CpG islands.
Estimation of β(t): To perform model fitting, we projected the functional term β(t) onto a
linear spline basis:
β(t) = b1 + b2t+
Kb∑
k=3
bk (t− δk)+ with δk ∈ [0, 1]
where δk is the k
th knot along the interval [0, 1] and (t− δk)+ is the positive part function:
(t− δk)+ =
 t− δk, if t ≥ δk0, if t < δk
We further defined our spline basis vector:
ϕ(t) = {ϕ1(t), ϕ2(t), . . . , ϕKb(t)} =
{
1, t, (t− δ3)+ , (t− δ4)+ , . . . , (t− δKb)t
}
and a coefficient vector: b = (b1, b2, .., bKb)
T so that we may induce smoothing by assuming b ∼
N(0,D), where D is a penalty matrix corresponding to the particular spline basis ϕ(t). Since
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For ease of notation, we denoted JXφ as the n × Kb matrix with the (i, k)th entry equal to∫ 1
0 fTi(t)ϕk(t)dt and Z as the n× p matrix with the i
th row equal to Zi, where p is the number of
covariates. The model can be written in matrix format as:
Y |X(t) =
[
1n, JXϕ , Z
] [
αT , bT , γT
]
+ ε
b ∼ N(0, D)







The advantage of the PFR approach is it borrows the info from non-local probes and one
limitation is the running time of PFR is relative long compare to other single imputation approach.
4.3.2 CUE: CpG impUtation Ensemble
Denote the different imputation models by fk, with k = {1, ..,K}. Then the imputed values
for the ith probe with the kth imputation model are denoted by Ŷik = fk(Zi) (or fk(Zi, Xi(t)) if we




wi,kŶik , with weights wi,k ∈ [0, 1] k = {1, ..,K}
Note with β methylation values, we have the natural constraint Yi, Ŷik ∈ [0, 1].
Selection of Weights: One challenge problem is how to select weights for the ensemble
imputation methods. Here we list three different approaches to select the weights. First, equal
weights: wj,1 = wj,2 = · · · = wJ,K = 1K ; Second, best-single-method weights (0-1 weights): wj,best =
1, the other weights = 0; Third, theoretical optimal weights: given the predictions from different
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models, we need to solve the following probe specific optimization problem to learn the optimal




Li(wi) = ||Yi − Ŷi.||2 = ||Yi −
∑K
k=1wi,kŶik||2
subject to wi = [wi,1, wi,2, .., wi,K ]
T
In general, the first one is simple and robust but could not guarantee the improvement of the
performance. The second one and the third one would be guaranteed to be no worse than any single
imputation tools by design. The third one is actually the best linear fitting on the training data,
which tends to overfits on the training data. The above convex optimization can be efficiently solved
by standard convex optimizer. However, in the real application examples, the true Yi could not be
observed. One possible remedy is that we solve the optimal weights for the training dataset where
we observe the true Yi and directly applied learning weights to the test dataset. If the training
dataset and the test dataset are generated from same distribution, then the optimal weights we
learned from training datasets can be generalized to the test dataset easily. If not, other domain
adaption and transfer learning techniques can be incorporated to get more accurate estimation of
the optimal weights for the test dataset. But in this chapter, we would assume that the training
and test dataset are generated from the same dataset.
In this study, we adopted the second approach to seek for the balance between imputation
performances and robustness. Based on the training results, we select the best method for imputa-
tion at each CpG site and employ that model for the final prediction. Here the model comparison
criterion is out-of-bag predicted MSE. Suppose the k − th model outperforms other methods on a
CpG site (i.e., with lowest out-of-bag prediction MSE), then wk = 1 and wi = 0 for i 6= k. Namely,
ŷEns = ŷk for this CpG site if the k − th model performs the best. Consequently, the performance
of the ensemble method outperforms other single methods by design.
4.3.3 Imputation quality assessment and control
Six-fold cross-validation was used to assess imputation quality. For each split, the full dataset
was randomly divided into a training set, consisting of 5/6 of the total samples, and a testing
set (1/6 of the total samples). For each testing set, we only kept data at the probes common to
56
HM450 and HM850 (shared probes, or predictor probes), and masked methylation values of HM850-
specific probes. For the training set, we employed methylation measurements on the shared probes
as predictors to impute methylation values at HM850 specific probes. Since most HM450 probes
are measured by both HM850 and HM450 platforms, the predictors used in our model can be
methylation levels for these shared probes measured from either array. Note that our prediction
model was built under the realistic and thus more challenging scenario where we used as predictors
the measurements from HM450 array instead of those from HM850 array, which would require
the training dataset had measurements from both arrays. Specifically, we first fitted our PFR
model, learning the relationship between the methylation values of the shared and HM450-specific
probes. Second, we used the fitted model to impute the masked values of HM850 probes from the
HM450 data in the testing set. In the end, we evaluated the imputation performance by integrating
imputation results from all 6 splits.
As measures of the imputation quality, we employ both the predicted root mean squared error
(RMSE) and the accuracy with 0.5 as the threshold. Conventionally, if the raw methylation value
is above the threshold, we call it methylated, and unmethylated otherwise. We employ two quality
control criteria: the probe-level predicted RMSE > 0.05 and the probe-level predicted accuracy
> 95% when dichotomizing DNA methylation level at a cutoff of 0.5.
4.4 Real data results
In this study, we used DNA methylation data of both HM450 and HM850 from two cohorts,
namely the Posttraumatic Stress Disorder (PTSD) genetics repository (Logue et al., 2017) (144
whole blood samples) and Extremely Low Gestational Age Newborns (ELGAN) study (Santos
et al., 2019) (127 placenta samples). We first comprehensively assessed five methods: three tradi-
tional statistical methods, k-nearest-neighbors (KNN), logistic regression (Logistic) and penalized
functional regression (PFR) model (Goldsmith et al., 2011; Zhang et al., 2016); and two modern
machine learning algorithms, random forest (RF) and XGBoost. Their performances were system-
atically evaluated using six-fold cross-validation on the two cohorts separately.
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4.4.1 Cross validation results on ELGAN and PTSD
In this dissertation, we mainly focused on imputation within the same tissue, because for most
studies, samples are usually collected for the same tissue and more importantly because methylation
profiles tend to differ profoundly, preventing accurate or even meaningful imputation across tissues.
We assessed imputation quality within each cohort by conducting the six-fold cross validation,
separately on whole blood samples from PTSD and placenta samples from ELGAN. Note that all
samples in the two cohorts (ELGAN and PTSD) in this study have both 850K and 450K data and
thus could be used to evaluate our CUE method using the aforementioned cross-validation strategy.
Note the time complexity of our method is O(n) and we can easily impute each target probe in
parallel to decrease clock computation time, where n is the number of the HM850-specific probes
(in this case n = 339, 033 HM850-specific probes).
For the ELGAN dataset, RF achieved the fastest speed, the smallest root mean square error
(RMSE) (0.099) and the highest accuracy (measured by dichotomizing DNA methylation level at
a cutoff of 0.5) (94.60%) among the five imputation tools we compared (Table 1). KNN, PFR
and XGBoost performed slightly worse than RF with regard to RMSE (decreases by 0.004-0.025),
and had 0.34%-1.96% loss in terms of classification accuracy for dichotomous methylation status.
Logistic regression can achieve an accuracy higher than 90% but performed the worst in RMSE.
Table 4.1: Imputation performances in the ELGAN dataset and the PTSD dataset. For all the compu-
tational results reported in tables of this chapter, we used 15 CPUs. Logistic regression did not converge
(D.N.C.) for ELGAN dataset.
PTSD performance ELGAN performance
Accuracy RMSE Time Accuracy RMSE Time
KNN 98.02% 0.054 3hrs 92.64% 0.124 2.5hrs
Logistic D.N.C. D.N.C. D.N.C. 91.76% 0.263 2.5hrs
PFR 98.41% 0.044 18.5hrs 93.50% 0.114 6hrs
RF 98.02% 0.054 5hrs 94.60% 0.099 3hrs
XGBoost 98.59% 0.040 3hrs 94.26% 0.103 3hrs
Similarly, we obtained the six-fold cross validation results in the PTSD dataset. Among the
five single imputation results, the winner in this PTSD dataset is XGBoost, in contrast to random
forest for the ELGAN dataset. Specifically, XGBoost achieved the smallest RMSE (0.04) and the
highest accuracy (98.59%) (Table 4.1). In fact, random forest was the not even the second best.
Penalized functional regression approach achieved a 0.39% higher accuracy and a lower (by 0.01)
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RMSE than random forest. Compared with previous results from the ELGAN dataset, this set of
results suggests that there was no uniformly best single imputation method across different tissues
or datasets, which inspired our ensemble imputation framework.
We further reported the proportions of CpG sites where each imputation method outperformed
all others in PTSD (Fig. 4.2). Results showed that all four viable imputation methods (we ex-
cluded logistic regression since it failed to converge) are champion at some CpG sites, which again
motivates the development of an ensemble imputation framework. For more than 42% of the CpG
sites, random forest achieved the lowest RMSE (Fig. 4.2). In total, random forest and XGBoost
outperformed the other methods for 70% of CpG sites. In contrast, penalized functional regression
was the best imputation model for 26% of the CpG sites while XGBoost for 30% CpG sites (Fig.
4.2). Last but not the least, for 1.7% of the probes (5,596 probes) KNN performed the best (Fig.
4.2).
Figure 4.2: Proportions of Best Method for Each Targeted Site in PTSD.
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Figure 4.3: Imputed Performances Before (Left Bar) and After QC (Right Bar) for QCed Probes in
PTSD. (a) RMSE comparisons. (b) 1- Accuracy (classification error) comparisons. Different colors represent
different methods. The horizontal dash line is the lowest value corresponding to the best method.
We developed CUE, CpG imputation Ensemble, which employed an ensemble approach to
improve prediction of methylation values at HM850 specific CpG sites. We also filtered out the
probes failed to pass the quality control (QC) criteria (RMSE < 0.05 and accuracy > 95% at CpG
site level). Before QC, all the methods’ predicted RMSE are below 0.06 and CUE performed best
(Fig. 4.3). The predicted RMSE of individual tools can be reduced by 5.8%-30.3% with CUE. After
post-imputation QC, the predicted RMSE of all the tools were reduced by 37.9%− 50.0%. Among
all the 339,033 HM850-only CpG sites shared between ELGAN and PTSD, CUE out-performed
all individual methods at 289,604 (85.4%) sites (Table C.1). Specifically, CUE achieved the lowest
predicted RMSE (0.026) and the highest accuracy (99.97%), compared with individual methods
with RMSE ranging 0.029-0.036 (improved by 10.0%− 27.4%) and with accuracy 99.95%− 99.97%
.
When evaluating prediction accuracy, we use 0.5 as the conventional cut-off for the methylation
states (labeled as 1 [or methylated] if the beta methylation level is above 0.5; 0 [or unmethylated]
otherwise). Our CUE method is robust to different cut-offs (thresholds) and achieves the highest
accuracy across all thresholds (Fig. C.2). Logistic regression seems sensitive to the threshold
probably because it is trained based on labels defined at the cutoff of 0.5.
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4.4.2 Independent validation results: cross-dataset performances
Although six-fold cross-validation experiments above provide useful information, in reality,
imputation will be performed in dataset(s) distinct from the one based on which training models
are built. To provide more honest performance estimates and to assess the transportability of
models trained by our CUE and individual methods, we examined their performances across the
two datasets. With the presence of many systematic differences between the two datasets, we first
attempted to correct for batch effects. Specifically, we employed Combat (Johnson, Li et al. 2007)
to generate a harmonized dataset after pooled together data from the two cohorts. We then trained
methylation prediction models with the harmonized ELGAN dataset and tested on the harmonized
PTSD dataset. Among the five single imputation methods, random forest achieved the highest
accuracy (95.23%) and the lowest predicted RMSE (0.07). KNN is the fastest model with 1.4%
loss in accuracy and 0.02 loss.
4.4.3 DNA methylation varies across different tissues
DNA methylation data varies across different tissues inherently. Separately for each cohort
(tissue), we classified DNA methylation probes into three categories: unmethylated probe if β
values across all samples in the cohort are less than 0.5; methylated probe if β values across all
samples in the cohort are greater than 0.5; bi-modal probe otherwise. We reported the proportions
of three different categories probes for 339,033 HM850-targeted probes (Fig. 4.4). For PTSD
cohort, almost 91% probes are either methylated or unmethylated, while only 54% for ELGAN. In
general, bi-modal probes are more difficult to impute because of their complexity inherently. One
indicator is that their variances tend to be larger than the rest probes.
Figure 4.4: Proportions of Three-Category HM850-specific Probes in Two Studies.
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4.5 Discussion
In this study, we developed an ensemble method, CUE, to enhance prediction accuracy when
imputing methylation values across different platforms. Although our initial goal is to extende
our previously developed penalized functional regression (PFR) framework, and systematically
evaluated its performance with multiple alternative methods. Results from real data analyses
suggest that there is no uniformly single best imputation method across different datasets or tissues,
which motivates our ensemble method, CUE. Under three different scenarios with data from two
different cohorts (one with samples from placenta and the other with samples from whole blood),
CUE outperforms all the single imputation tools in terms of both predicted root mean square error
(measuring methylation values with a continuous scale) and predicted accuracy (dichotomizing
methylation values). CUE also leads to a larger number of probes well imputed (that is, passing
post-imputation quality control) than any single imputation method.
CUE can produce accurate imputation results when the training and testing data characterize
the same tissue under similar conditions. With our CUE imputation framework, we can combine
data from multiple platforms, enabling higher resolution and more powerful downstream analysis.
For example, the combined dataset can be used to boost the power not only for epigenome wide
association (EWAS) study, but also for mQTL analysis, as well as multi-omics integrative analysis.
Regardless of the epigenetic architecture underlying phenotype(s) of interest, we expect our method
to facilitate more efficient utilization of methylation data from multiple platforms and to foster
advances in understanding the impact of DNA methylation on phenotype(s) of interest.
To further assess the generalizability of prediction model trained on data from the same tissue
but from different institutions, we would benefit from the availability of such data. However, we
are not aware of such data despite our keen efforts to assemble such datasets. Future studies are
highly warranted when data become available.
In summary, findings in this study suggest that our CUE ensemble methylation imputation
method is valuable for imputing from HM450 to HM850. DNA methylation data inherently vary
across tissues and ours and others’ results (Zhang et al., 2016) suggest that it would be prudent to
train separate imputation prediction models for different tissues. From this study, we provide two
sets of imputation models: one for whole blood and the other for placenta. Our study is the first
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to impute from HM450 to HM850 for two different tissues. We believe our CUE method as well
as the pre-trained imputation models across the two tissues will be of value to many investigators,




Machine learning methods are of increasing importance in both foundations of statistical infer-
ence and modern genetics applications. In the dissertation, we first focus on the foundation of the
inference problem in Chapter 2. Specifically, we introduce a new ML-based inference framework,
deep fiducial inference, accompanied by a computational algorithm, approximate fiducial computa-
tion. Then, we consider two ML applications, one in genetics in Chapter 3 and one in epigenetics
in Chapter 4.
In Chapter 2, we propose a fiducial autoencoder for the circumstance in which the analytical
form of the inverse function is not available or the marginal fiducial density is intractable. The uni-
versal approximation theorem provides theoretical guarantees for the approximation performance
of our FAE, and our simulations further validate our approach. The proposed FAE can accurately
approximate the inverse function, and it can be efficiently combined with the AFC algorithm to
provide valid and accurate inferences of the true parameters. The competitive performance of AFC
corrected FAE solutions both in terms of efficiency and accuracy suggests that this is a promising
area for future research.
In Chapter 3, we present SMNN, a batch effect correction method for scRNA-seq data via
supervised mutual nearest neighbor detection. Our SMNN explicitly considers cell type label in-
formation to perform supervised mutual nearest neighbor matching, thus empowered to extract
only desired neighbors from the same cell type. Extensive simulation and real data benchmarking
suggest that our SMNN can better rescue biological features and thereof provide improved cluster
results. Therefore, we anticipate that our SMNN is valuable for the integrated analysis of multiple
scRNA-seq datasets.
In Chapter 4, we develop an ensemble method, CUE, to enhance prediction accuracy when
imputing methylation values across different platforms. CUE can produce accurate imputation
results when the training and testing data characterize the same tissue under similar conditions.
With our CUE imputation framework, we can combine data from multiple platforms, enabling
higher resolution and more powerful downstream analysis. Findings in this study suggest that our
CUE ensemble methylation imputation method is valuable for imputing from HM450 to HM850.
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APPENDIX A
PYTHON CODES FOR FAE
Listing A.1: Python code for BOD example
import keras
import t en s o r f l ow as t f
from keras import backend as K
import numpy as np
from keras . l a y e r s import Input , Dense
from keras . models import Model , Sequent i a l
from keras . models import model f rom json
from keras . op t im i z e r s import RMSprop , Adam
import matp lo t l i b . pyplot as p l t
import sys
import os
class FAE( ) :
def i n i t ( s e l f ) :
# Input shape
s e l f . samples = 120000
s e l f . n o i s e v a r = 0.015
s e l f . dim = 5
s e l f . channe l s = 1
s e l f . opt imize r = Adam( )
# I n i t i a l z i e input
x input = Input ( shape=( s e l f . dim , s e l f . channe l s ) , name=’ x ’ )
y input = Input ( shape=( s e l f . dim , s e l f . channe l s ) , name=’ y ’ )
z input = Input ( shape=( s e l f . dim , s e l f . channe l s ) , name=’ z ’ )
# Bui ld encoder
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s e l f . encoder = s e l f . bu i l d encode r ( )
s e l f . encoder0 = s e l f . bu i ld encode r0 ( )
s e l f . encoder1 = s e l f . bu i ld encode r1 ( )
code = s e l f . encoder ( [ x input , y input , z input ] )
t0 = s e l f . encoder0 ( [ code ] )
t1 = s e l f . encoder1 ( [ code ] )
# Bui ld decoder
s e l f . decoder = s e l f . bu i l d decode r ( )
y hat = s e l f . decoder ( [ t0 , t1 , x input , z input ] )
# The combined model ( conect encoder and decoder )
s e l f . autoencoder = Model ( inputs =[ x input , y input , z input ] ,
outputs =[ y hat , t0 , t1 ] )
s e l f . autoencoder . compile ( opt imize r = s e l f . opt imizer ,
l o s s ={ ’ decoder ’ : ’ mean squared error ’ ,
’ encoder0 ’ : ’ mean squared error ’ ,
’ encoder1 ’ : ’ mean squared error ’ } ,
l o s s w e i g h t s={ ’ decoder ’ : 5 ,
’ encoder0 ’ : 10 ,
’ encoder1 ’ : 3})
s e l f . autoencoder . summary ( )
def bu i ld encode r ( s e l f ) :
# t h i s i s our input p l a c e h o l d e r
x input = Input ( shape = ( s e l f . dim , s e l f . channe l s ) ,name=’ x ’ )
y input = Input ( shape = ( s e l f . dim , s e l f . channe l s ) ,name=’ y ’ )
z input = Input ( shape=( s e l f . dim , s e l f . channe l s ) , name=’ z ’ )
# ” encoded ” i s the encoded r e p r e s e n t a t i o n o f the input
encoded=keras . l a y e r s . concatenate ( [ x input , y input , z input ] )
encoded = Dense (32 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
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encoded = Dense (64 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (128 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (512 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (128 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (512 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (128 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (32 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoder = Model ( inputs =[ x input , y input , z input ] , outputs=
encoded , name=” encoder ” )
encoder . summary ( )
return encoder
def bu i ld encode r0 ( s e l f ) :
encoded0 = Input ( shape=( s e l f . dim , 32) , name=’ code0 ’ )
encoded = Dense (128 , a c t i v a t i o n=’ r e l u ’ ) ( encoded0 )
encoded = Dense (64 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (32 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
t0 cand ida t e = Dense (1 , a c t i v a t i o n=’ r e l u ’ ,name=’ t0 hat ’ ) (
encoded )
et0 = keras . l a y e r s . AveragePooling1D ( p o o l s i z e=s e l f . dim ,
s t r i d e s=None , padding=’ v a l i d ’ ,name=’ et0 ’ ) ( t 0 cand ida t e )
encoder0 = Model ( inputs=encoded0 , outputs=et0 , name=” encoder0 ”
)
encoder0 . summary ( )
return encoder0
def bu i ld encode r1 ( s e l f ) :
# d e f i n e encoder1
encoded = Input ( shape=( s e l f . dim , 32) , name=’ code1 ’ )
t1 cand ida t e = Dense (1 , a c t i v a t i o n=’ r e l u ’ ,name=’ t1 hat ’ ) (
encoded )
et1 = keras . l a y e r s . AveragePooling1D ( p o o l s i z e=s e l f . dim ,
s t r i d e s=None , padding=’ v a l i d ’ ,name=’ et1 ’ ) ( t 1 cand ida t e )
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encoder1 = Model ( inputs=encoded , outputs=et1 , name=” encoder1 ” )
encoder1 . summary ( )
return encoder1
def bu i ld decode r ( s e l f ) :
# t h i s i s our input p l a c e h o l d e r
dt0 = Input ( shape = (1 , s e l f . channe l s ) ,name=’ dt0 ’ )
dt1 = Input ( shape = (1 , s e l f . channe l s ) ,name=’ dt1 ’ )
x input = Input ( shape = ( s e l f . dim , s e l f . channe l s ) ,name=’ x ’ )
z input = Input ( shape=( s e l f . dim , s e l f . channe l s ) , name=’ z ’ )
def dg ( ip ) :
t t0 = ip [ 0 ]
t t1 = ip [ 1 ]
tx2 = ip [ 2 ]
tz2 = ip [ 3 ]
ty = tt0 ∗ (1−K. exp(− t t1 ∗ tx2 ) ) + tz2
return ty
y hat = keras . l a y e r s . Lambda( dg ) ( [ dt0 , dt1 , x input , z input ] )
encoder = Model ( inputs =[dt0 , dt1 , x input , z input ] , outputs=
y hat , name=” decoder ” )
encoder . summary ( )
return encoder
def load data BOD ( s e l f , s o r t = True ) :
# Generate BOD Data
m = s e l f . dim
n = s e l f . samples
x=np . array ( [ 2 . 0 , 4 . 0 , 6 . 0 , 8 . 0 , 1 0 . 0 ] )
def DataGenerateFunction ( z , t0 , t1 ,m, n) :
y = z + np . diag ( t0 ) @ (1 − np . exp(− ( t1 . reshape (n , 1 ) @
x . reshape ( ( 1 ,m) ) ) ) )
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return y
def model1 (m = 5 , n = 30) :
t0 = np . random . uniform ( 0 . 4 , 1 . 2 , n )
t1 = np . random . uniform (0 .000001 , 0 . 2 , n )
z = np . random . normal (0 , s e l f . no i s e var , (n ,m) )
y = DataGenerateFunction ( z , t0 , t1 ,m, n)
return (m, n , y , z , t0 , t1 )
# setup the random seed
np . random . seed (20200521)
(m, n , y , z , t0 , t1 ) = model1 (m = m, n = n)
i f s o r t == True :
p = y . a r g s o r t ( a x i s =1)
y . s o r t ( a x i s =1)
z=np . array ( [ z [ i , p [ i , ] ] for i in range (n) ] )
y=y [ : , : , np . newaxis ]
z=z [ : , : , np . newaxis ]
t0=t0 [ : , np . newaxis , np . newaxis ]
t1=t1 [ : , np . newaxis , np . newaxis ]
r =0.8 # r a t i o o f t r a i n and v a l i d a t i o n
t r a i n y=y [ 0 : int (n∗ r ) , : , : ]
t r a i n z=z [ 0 : int (n∗ r ) , : , : ]
v a l i d y=y [ int (n∗ r ) : n , : , : ]
v a l i d z=z [ int (n∗ r ) : n , : , : ]
t r a i n t 0=t0 [ 0 : int (n∗ r ) , : , : ]
t r a i n t 1=t1 [ 0 : int (n∗ r ) , : , : ]
v a l i d t 0=t0 [ int (n∗ r ) : n , : , : ]
v a l i d t 1=t1 [ int (n∗ r ) : n , : , : ]
x = np . t i l e (x , ( n , 1 ) )
x = x [ : , : , np . newaxis ]
t r a i n x = x [ 0 : int (n∗ r ) , : , : ]
v a l i d x = x [ int (n∗ r ) : n , : , : ]
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print ( t r a i n y . shape [ 0 ] , ’ t r a i n samples ’ )
print ( v a l i d y . shape [ 0 ] , ’ t e s t samples ’ )
return ( t ra in x , t ra in y , t r a i n z , t r a i n t 0 , t r a i n t 1 , va l id x ,
va l id y , v a l i d z , v a l i d t 0 , v a l i d t 1 , r )
def train AE ( s e l f , epochs , b a t c h s i z e =256 , s o r t = True ) :
( t r a in x , t ra in y , t r a i n z , t r a i n t 0 , t r a i n t 1 , va l id x , va l id y ,
v a l i d z , v a l i d t 0 , v a l i d t 1 , r ) = s e l f . load data BOD ( s o r t =
True )
s e l f . t r a i n = s e l f . autoencoder . f i t ({ ’ x ’ : t r a in x , ’ y ’ : t r a in y ,
’ z ’ : t r a i n z } ,
{ ’ decoder ’ : t r a in y ,
’ encoder0 ’ : t r a i n t 0 ,
’ encoder1 ’ : t r a i n t 1 } ,
b a t c h s i z e=batch s i z e , epochs=epochs , verbose =1,
v a l i d a t i o n d a t a =({ ’ x ’ : va l id x , ’ y ’ : va l id y , ’ z ’ :
v a l i d z } ,
{ ’ decoder ’ : va l id y ,
’ encoder0 ’ : v a l i d t 0 ,
’ encoder1 ’ : v a l i d t 1 }
) )
p r e d t r a i n = s e l f . autoencoder . p r ed i c t on ba t ch ({ ’ x ’ : t r a in x ,
’ y ’ : t r a in y , ’ z ’ : t r a i n z })
p r e d v a l i d = s e l f . autoencoder . p r ed i c t on ba t ch ({ ’ x ’ : va l id x ,
’ y ’ : va l id y , ’ z ’ : v a l i d z })
# np . savez ( ’ p r e d t r a i n v a l i d . npz ’ , p r e d t r a i n=p r e d t r a i n ,
p r e d v a l i d=p r e d v a l i d ,
# t r a i n y=t r a i n y , t r a i n t 0=t r a i n t 0 , t r a i n t 1=t r a i n t 1 )
# e v a l u a t e the model
s c o r e s = s e l f . autoencoder . eva luate ( x=[ va l id x , va l id y ,
v a l i d z ] , y=[ va l id y , v a l i d t 0 , v a l i d t 1 ] , verbose =0)
print ( ”%s : %.2 f ” % ( s e l f . autoencoder . metr ics names [ 0 ] , s c o r e s
[ 0 ] ) )
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print ( ”%s : %.2 f ” % ( s e l f . autoencoder . metr ics names [ 1 ] , s c o r e s
[ 1 ] ) )
print ( ”%s : %.2 f ” % ( s e l f . autoencoder . metr ics names [ 2 ] , s c o r e s
[ 2 ] ) )
print ( ”%s : %.2 f ” % ( s e l f . autoencoder . metr ics names [ 3 ] , s c o r e s
[ 3 ] ) )
def test AE ( s e l f , t0 =0.8 , t1 =1.0 , n t e s t =1000 , s o r t = True ) :
m = s e l f . dim
x=np . array ( [ 2 . 0 , 4 . 0 , 6 . 0 , 8 . 0 , 1 0 . 0 ] )
def mode l t e s t ( ) :
z = np . random . normal (0 , s e l f . no i s e var , (1 ,m) )
y = z + t0 ∗ (1 − np . exp(− ( t1 ∗ x ) ) )
return (m, n te s t , y , z , t0 , t1 )
np . random . seed (20200526) # 0504
(m, n te s t , y t e s t , z t e s t , t0 , t1 ) = mode l t e s t ( )
y t e s t = np . array ( [ 0 . 1 5 2 2 0 7 1 , 0 .29667172 , 0 .41254479 ,
0 .48237946 , 0 . 56707723 ] )
p t e s t = np . array ( [ 0 , 1 , 2 , 3 , 4 ] )
print ( y t e s t )
print ( p t e s t )
y t e s t = np . t i l e ( y t e s t , ( n t e s t , 1 ) )
y t e s t = y t e s t [ : , : , np . newaxis ]
np . random . seed (20200504)
z t e s t = np . random . normal (0 , s e l f . no i s e var , ( n t e s t ,m) )
i f s o r t == True :
z t e s t=np . array ( [ z t e s t [ i , p t e s t ] for i in range (
n t e s t ) ] )
z t e s t = z t e s t [ : , : , np . newaxis ]
x t e s t = np . t i l e (x , ( n t e s t , 1 ) )
x t e s t = x t e s t [ : , : , np . newaxis ]
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pred = s e l f . autoencoder . p r ed i c t on ba t ch ({ ’ x ’ : x t e s t , ’ y ’ :
y t e s t , ’ z ’ : z t e s t })
t 0 f a e = pred [ 1 ]
t 1 f a e = pred [ 2 ]
np . save ( ”BOD t0 %.3 f . npy”%t0 , t 0 f a e )
np . save ( ”BOD t1 %.3 f . npy”%t1 , t 1 f a e )
np . save ( ”BOD y hat . npy” , pred [ 0 ] )
i f name == ’ ma in ’ :
f a e = FAE( )
f a e . train AE ( epochs =10, b a t c h s i z e =500 , s o r t = False )
f a e . test AE ( t0 =0.9 , t1 =0.1 , n t e s t =10000 , s o r t = False )
Listing A.2: Python code for non-linear data generating example
#!/ usr / b in /env python3
# −∗− coding : u t f−8 −∗−
”””




import numpy as np
from keras import backend as K
from keras . l a y e r s import Input , Dense
from keras . models import Model
from keras . op t im i z e r s import RMSprop , Adam
import matp lo t l i b as mpl





def DataGenerateFunction ( z ,mu,m) :
x = np . t ranspose (np . t i l e (mu, (m, 1 ) ) ) + np . matmul (np . d iag (np . power (mu, ( 3 / 2 ) )
) , z )
return x
def model1 (m = 10 , n = 30) :
mu = np . random . uniform (0 , 6 , n)
z = np . random . normal (0 , 1 , (n ,m) )
x = DataGenerateFunction ( z ,mu,m)
return (m, n , x , z , mu)
(m, n , x , z , mu0) = model1 (m = 3 , n = 100000)
x=x [ : , : , np . newaxis ]
z=z [ : , : , np . newaxis ]
r =0.8 # r a t i o o f t r a i n and v a l i d a t i o n
t ra in X=x [ 0 : int (n∗ r ) , : , : ]
t r a i n z=z [ 0 : int (n∗ r ) , : , : ]
va l id X=x [ int (n∗ r ) : n , : , : ]
v a l i d z=z [ int (n∗ r ) : n , : , : ]
print ( t ra in X . shape [ 0 ] , ’ t r a i n samples ’ )
print ( va l id X . shape [ 0 ] , ’ t e s t samples ’ )
######################################################
# Define the FAE
######################################################
inChannel = 1
# t h i s i s our input p l a c e h o l d e r
x input = Input ( shape = (m, inChannel ) ,name=’ x ’ )
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z input = Input ( shape=(m, inChannel ) , name=’ z ’ )
# ” encoded ” i s the encoded r e p r e s e n t a t i o n o f the input
encoded=keras . l a y e r s . concatenate ( [ x input , z input ] )
encoded = Dense (64 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (128 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (512 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (128 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (512 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (128 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (64 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (128 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (64 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
encoded = Dense (32 , a c t i v a t i o n=’ r e l u ’ ) ( encoded )
mu = Dense (1 , a c t i v a t i o n=’ r e l u ’ ,name=’ mu hat ’ ) ( encoded )
mu1 = keras . l a y e r s . AveragePooling1D ( p o o l s i z e =3, s t r i d e s=None , padding=’ v a l i d ’
) (mu)
def dg ( ip ) :
mu1 = ip [ 0 ]
z2 = ip [ 1 ]
mu2=K. repea t e l ement s (mu1, 3 , 1 )
return mu2 + K.pow(mu2, 3 / 2 ) ∗ z2
decoded = keras . l a y e r s . Lambda( dg ) ( [ mu1 , z input ] )
FAE = Model ( inputs =[ x input , z input ] , outputs =[decoded , mu1 ] )
FAE. compile ( opt imize r = Adam( ) ,
l o s s ={ ’ lambda 1 ’ : ’ mean squared error ’ ,
’ ave rage poo l ing1d 1 ’ : ’ mean squared error ’ } ,
l o s s w e i g h t s={ ’ lambda 1 ’ : 1 ,
’ ave rage poo l ing1d 1 ’ : 1})
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FAE. summary ( )
###### Model F i t t i n g
b a t c h s i z e = 250
epochs = 10
FAE train=FAE. f i t ({ ’ x ’ : tra in X , ’ z ’ : t r a i n z } ,
{ ’ lambda 1 ’ : tra in X ,
’ ave rage poo l ing1d 1 ’ : mu0 [ 0 : int (n∗ r ) , np . newaxis , np . newaxis
] } ,
b a t c h s i z e=batch s i z e , epochs=epochs , verbose =1,
v a l i d a t i o n d a t a =({ ’ x ’ : val id X , ’ z ’ : v a l i d z } ,
{ ’ lambda 1 ’ : val id X ,
’ ave rage poo l ing1d 1 ’ : mu0 [ int (n∗ r ) : n , np .
newaxis , np . newaxis ] }) )
[ FAE pred X , FAE pred mu]=FAE. p r e d i c t ({ ’ x ’ : val id X , ’ z ’ : v a l i d z })
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APPENDIX B
ADDITIONAL PERFORMANCE EVALUATIONS FOR SMNN
In this study, we further evaluated several other computing and performance aspects of SMNN.
First, we evaluated SMNN’s robustness to the availability of only partial cell type information.
Specifically, we performed SMNN correction for two hematopoietic datasets by feeding cluster
labels for either one or two of the three cell types. The results showed that, under such partial
label information, SMNN still better mixed cells of the same cell type across batches than MNN
method (Appendix B: Fig. B.2a-c and e-g), consistent with the best/lowest F values from the
SMNN-corrected results F value, compared with uncorrected and MNN-corrected data. Specifically,
SMNN reduced the differentiation between the two batches by 89.7% to 94.0% (73.9% to 96.7%) on
top of the MNN corrected results when using label information for only one (two) of the three cell
types, respectively (Appendix B: Fig. B.2d and h). These results indicate that SMNN is robust
and superior even with partial cell type annotation information.
Furthermore, to assess whether the differentially expressed genes (DEGs) identified in SMNN
and MNN corrected data were sensitive to the significance threshold selected, we show ROC curves
to illustrate the ability of identifying DEGs among CMP, GMP and MEP cells after SMNN and
MNN correction, at various adjusted p-value threshold, treating those identified in uncorrected
batch 1 as working truth. The results showed that, in almost all cases, SMNN outperformed MNN
(Appendix B: Fig. B.9). The only exception is for DEGs up-regulated in GMP when compared
to MEP, where the ROC curves of SMNN and MNN are comparable (Appendix B: Fig. B.9e).
These results suggest that our DEG analysis is not sensitive to the p-value cutoff we use for DEG
detection.
Lastly, when the cell population compositions are unbalanced between two batches, we ex-
tracted the three major cell types out from two hematopoietic datasets, in order to construct two
new batches with a more apparent difference in cell group composition. In the new batch 1, the
proportion of CMP, GMP and MEP cells are 40.4%, 15.1% and 44.5%, while those are 17.6%,
42.3% and 40.1% in new batch 2. Then we performed both MNN and SMNN correction across
the new batches. The results showed that SMNN outperformed MNN that SMNN reduced the
differentiation between the two batches (measured by the F value) by 11.3% on top of the MNN
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corrected results (Appendix B: Fig. B.11), indicating that SMNN is robust to the cell population
composition.










































Figure B.1: Performance of SMNN and MNN in the simulation data using the model in
Haghverdi et al. (2018). (a) Histogram of the angles (surrogate for orthogonality) for the simulation
data using the model in Haghverdi et al. (2018). (b) Frobenius norm distance between two batches after
SMNN and MNN correction in simulation data under orthogonal (left) and non-orthogonal scenarios (right).
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Figure B.2: Performance of SMNN in two hematopoietic datasets with partial cell type labels.
(a-c) UMAP plots for two hematopoietic datasets after SMNN correction with the cell type label only from
CMP, GMP and MEP cells, respectively. Solid and inverted triangle represent the first and second batch,
respectively; and different cell types are shown in different colors. (d) Logarithms of F-statistics for merged
data of the two batches before and after correction with MNN and SMNN. SMNN correction was performed
with the cell type label only from CMP, GMP and MEP cells, respectively. (e-g) UMAP plots for the two
hematopoietic datasets after SMNN correction with cell type label only from any two of the three cell types,
CMP, GMP and MEP cells. (h) Logarithms of F-statistics for merged data of the two batches before and
after correction with MNN and SMNN. SMNN correction was performed with the cell type label only from
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Figure B.3: UMAP plots for all the cell types in two hematopoietic datasets. (a), (b) and
(c) corresponds to uncorrected, MNN-corrected and SMNN corrected results, respectively. (d) Cell type
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Figure B.4: Comparison of differentially expressed genes (DEGs), identified in the merged
dataset by pooling batch 1 data with batch 2 data after SMNN and MNN correction. (a)
Overlap of DEGs up-regulated in GMP over CMP after SMNN and MNN correction. (b) Feature enriched
GO terms and the corresponding DEGs up-regulated in GMP over CMP. (c) Overlap of DEGs up-regulated
in MEP over CMP after SMNN and MNN correction. (d) Feature enriched GO terms and the corresponding
DEGs up-regulated in MEP over CMP. (e) Overlap of DEGs up-regulated in GMP over MEP after SMNN
and MNN correction. (f) Feature enriched GO terms and the corresponding DEGs up-regulated in GMP
over MEP. (g) Overlap of DEGs up-regulated in MEP over GMP after SMNN and MNN correction. (h)
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Figure B.5: Feature enriched GO terms and the corresponding differentially expressed genes
(DEGs) specifically identified in the merged dataset by pooling batch 1 data with batch 2 data
after MNN correction. (a) Feature enriched GO terms and the corresponding DEGs up-regulated in
CMP over GMP. (b) Feature enriched GO terms and the corresponding DEGs up-regulated in GMP over
CMP. (c) Feature enriched GO terms and the corresponding DEGs up-regulated in GMP over MEP. (d)




















Figure B.6: False negative rate (FNR) of DEGs (between CMP and GMP), identified in
uncorrected batch 1 and in SMNN or MNN-corrected batch 2. (a) FNR of the DEGs up-regulated
in CMP over GEP identified in batch 2 after SMNN and MNN correction. (b) FNR of the DEGs up-regulated











































































































Figure B.7: Reproducibility of DEGs (between CMP and MEP and between GMP and MEP).
(a) Reproducibility of DEGs up-regulated in CMP over MEP. (b) and (c) Precision and false negative rate
(FNR) of the DEGs up-regulated in CMP over MEP. (d) Reproducibility of DEGs up-regulated in MEP
over CMP. (e) and (f) Precision and FNR of the DEGs up-regulated in MEP over CMP. (g) Reproducibility
of DEGs up-regulated in GMP over MEP. (h) and (i) Precision and FNR of the DEGs up-regulated in GMP
over MEP. (j) Reproducibility of DEGs up-regulated in MEP over GMP. (k) and (l) Precision and FNR of





























































































































































































Figure B.8: Reproducibility of DEGs (between any two cell types, out of the three: CMP,
GMP and MEP). (a) reproducibility for DEGs up-regulated in CMP over GMP. (b) and (c) Precision
and false negative rate (FNR) of the DEGs up-regulated in CMP over GMP. (d) Reproducibility of DEGs
up-regulated in GMP over CMP. (e) and (f) Precision and FNR of the DEGs up-regulated in GMP over
CMP. (g) Reproducibility of DEGs up-regulated in CMP over MEP. (h) and (i) Precision and FNR of the
DEGs up-regulated in CMP over MEP. (j) Reproducibility of DEGs up-regulated in MEP over CMP. (k)
and (l) Precision and FNR of the DEGs up-regulated in MEP over CMP. (m) Reproducibility of DEGs
up-regulated in GMP over MEP. (n) and (o) Precision and FNR of the DEGs up-regulated in GMP over
MEP. (p) Reproducibility of DEGs up-regulated in MEP over GMP. (q) and (r) Precision and FNR of the
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Figure B.9: ROC curves for DEGs (between any two cell types, out of the three: CMP, GMP
and MEP) at various adjusted p-value thresholds. (a) ROC curve for DEGs up-regulated in CMP
over GMP. (b) ROC curve for DEGs up-regulated in GMP over CMP. (c) ROC curve for DEGs up-regulated
in CMP over MEP. (d) ROC curve for DEGs up-regulated in MEP over CMP. (e) ROC curve for DEGs
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Figure B.10: Performance comparison between SMNN and MNN in two 10X Genomics
datasets for human PBMC and T cells.(a-c) UMAP plots for PBMC and T cells datasets before and
after batch effect correction with MNN and SMNN, respectively. Solid and inverted triangle represent PBMC
and T cell datasets, respectively; and different cell types are shown in different colors. (d) Logarithms of
F-statistics for merged data of the two batches. (e) Overlap of DEGs up-regulated in T cells over B cells
after SMNN and MNN correction. (f) Feature enriched GO terms and the corresponding DEGs up-regulated
in T cells over B cells. (g) Overlap of DEGs up-regulated in B cells over T cells after SMNN and MNN
















































































Figure B.11: Performance of SMNN in two hematopoietic datasets with unbalanced cell pop-
ulation composition. (a-c) UMAP plots for two hematopoietic datasets before and after correction with
MNN and SMNN, respectively. Solid and inverted triangle represent the first and second batch, respectively;
and different cell types are shown in different colors. (d) Cell population proportions in the two batches.




ADDITIONAL RESULTS FOR CUE
Table C.1: Numbers and ratios of well-imputed sites. Quality control (QC) criterias for PTSD: RMSE
< 0.05 and Accruracy > 95%; QC for ELGAN: RMSE < 0.1 and Accruracy > 90%. The ratios are out of
339,033 HM850-only CpG sites.
PTSD (%) ELGAN (%)
KNN 249,425 (73.6%) 181,304 (53.5%)
Logistic D.N.C. 93,470 (27.6%)
PFR 269,745 (79.6%) 213,355 (62.9%)
RF 249,425 (73.6%) 236,645 (69.8%)
XGBoost 285,330 (84.2%) 224,317 (66.2%)
CUE 289,604 (85.4%) 238,090 (70.2%)
Figure C.1: Imputed Performances Before (Left Bar) and After QC (Right Bar) for QCed
Probes in ELGAN. (a) RMSE comparisons. (b) 1- Accuracy (classification error) comparisons. Different
colors represent different methods. The horizontal dash line is the lowest value corresponding to the best
method.
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Figure C.2: Imputation accuracy across different thresholds in the ELGAN dataset. Our CUE
method (black line) achieves the highest accuracy across all thresholds. Logistic regression (yellow line)
seems sensitive to the threshold probably because it is trained based on labels defined at the cutoff of 0.5.
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